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Molecular oxygen (O2) is vital for efficient energy production and improper oxygenation is
a hallmark of disease or metabolic dysfunction. In many pathologies, knowledge of tissue
oxygen levels (pO2) could aid in diagnosis and treatment planning. The gold standard for
pO2 measures in tissue are implantable probes, which are invasive, require surgery for
placement, and are inaccessible to certain regions of the body. Methods for determining
pO2 both non-invasively and quantitatively are lacking.
The slight paramagnetic nature of O2 provides opportunities to non-invasively
characterize pO2 in tissue via magnetic resonance (MR) techniques. As such, O2 can be
treated as a weak endogenous contrast agent for longitudinal relaxation and, therefore,
the measured longitudinal relaxation rate constant (R1) is directly proportional to pO2.
Precise characterization of R1 in the absence of oxygen (R1,0) and the relaxivity of O2 (r1)
would allow for an R1-based pO2 measurement.

x

Additionally, the effective transverse relaxation rate constant (R 2*) in tissue is strongly
affected by the magnetic susceptibility effects of deoxyhemoglobin within the vasculature.
Many forms of placental dysfunction, e.g., pre-eclampsia and intrauterine growth
restriction, are proposed to be caused by altered vasculature development within the
placenta, potentially leading to adverse outcomes for both mother and fetus. Improved
biomarkers of placental function would aide in optimal timing for early delivery once the
placenta can no longer support fetal development.
The objectives of this dissertation were to: 1) investigate the efficacy of an R 1-based
method of pO2 quantification in a tissue surrogate; and 2) apply MR methods of monitoring
pO2 in tissue and O2 within the vasculature in mouse models of disease and insufficiency
to assess placental development and function. For the first goal, Bayesian probability
theory-based model selection was used to evaluate potential models of longitudinal
relaxation in in vivo tissue and an in vitro tissue surrogate, crosslinked bovine serum
albumin (xBSA). xBSA was then used to investigate physiologic confounds to an R 1based method of pO2 quantification, including temperature, pH, and protein
concentration, and R1,0 and r1 were determined. For the second goal, mouse models of
both placental insufficiency and Zika virus infection during pregnancy were monitored in
late gestation for changes in volume, R1, and R2* at baseline and with a gas challenge to
assess the placental response to an altered environment.
It was found that 1) both in vivo and xBSA relaxation data are best fit with a biexponential
model and, therefore, xBSA is a good surrogate for tissue, in terms of longitudinal
relaxation; 2) physiologic confounds to an R 1-based method of pO2 quantification exert
considerable affects upon measured R1 and must, therefore, be precisely controlled or
xi

accounted for; 3) placental volume, R2*, and change in R2* due to a breathing gas
challenge hold promise as biomarkers of placental development and dysfunction.
These findings suggest that an R1-based method for pO2 quantification in vivo is likely not
feasible on a routine basis due to the small water relaxivity of pO 2 and confounds to the
analysis due to relaxation effects of tissue pH, temperature, and protein concentration,
but MR methods could provide much needed information regarding placental function in
high risk pregnancies and warrants further investigation.

xii

Chapter 1: Introduction
1.1 Motivation:
Improper oxygenation is a hallmark of many diseases or dysfunctions and knowledge of
molecular oxygen (O2) levels within the body (pO2) could aid in diagnosis and treatment
planning. Tumors characterized by hypoxia are known to have increased angiogenesis
and propensity for metastasis[1], as well as increased resistance to chemotherapy[2] and
radiation therapy[3] treatments. Hypoxia in adipose tissue has been proposed to drive
insulin resistance, leading to type II diabetes[4]. Exchange of respiratory gases is a major
role of the placenta, with insufficient exchange of O2 potentially inducing long-term
adverse effects for both mother and fetus[5, 6].
Implantable probes are considered the gold standard for measuring tissue pO2[7] but are
invasive in nature, requiring surgery for placement. Methods of determining tissue pO 2
non-invasively and quantitatively are lacking. Optical imaging techniques are sensitive to
levels of oxy- and deoxyhemoglobin[8], which can be modeled to yield information about
oxygen saturation[9-11] and metabolic rate of oxygen consumption[12]. While noninvasive, these techniques are limited to a depth of penetration on the order of a few
millimeters to a centimeter. Positron emission tomography (PET) can detect even low
levels of hypoxic tumor cells[13] but is limited by spatial resolution of a millimeter or more
and requires exposure to radioactive materials. Magnetic resonance (MR) techniques can
non-invasively probe the entirety of the body with sub-millimeter spatial resolution. Bloodoxygen-level dependent (BOLD) MR imaging (MRI) utilizes the magnetic susceptibility
1

differences in the vasculature due to oxy- and deoxyhemoglobin levels[14]. However,
quantitative BOLD experiments are quite challenging[15] and therefore results are often
expressed as relative changes with respect to baseline measurements. O 2 is slightly
paramagnetic and can therefore be regarded as a weak, endogenous longitudinal
relaxation rate constant (R1) contrast agent for MR. Therefore, measured R1 is in principle
directly proportional to tissue pO2.
The goal of this dissertation is twofold: 1) investigate efficacy of R 1-based pO2
quantification and 2) use MRI with a breathing gas challenge to investigate non-invasive
biomarkers of placental development and function in mouse models of insufficiency or
disease.

1.2 State of Research:
1.2.1 Basics of Nuclear Magnetic Resonance
Classically, a rotating object possesses the property of angular momentum which can be
visualized as a vector pointing along the axis of rotation. The quantum mechanical
counterpart to this property is quantized and inherent to elementary particles, i.e. protons,
neutrons, electrons, as well as composite particles and whole nuclei. Nuclear spin angular
momentum describes the spin state of the superposition of protons and neutrons within
the atomic nucleus, which can be described by a magnitude L of the form:

𝐿=

ℎ
[𝐼(𝐼 + 1)]1/2
2

2

where h is Planck’s constant and I is the nuclear spin quantum number, which takes the
form N/2, with N any non-negative integer. Nuclei with spin I are (2I+1)-fold degenerate,
with sublevels described by the quantity m which is of the form:
𝑚 = −𝐼, 𝐼 + 1, … ,0, … , 𝐼 − 1, 𝐼
The projection of this angular momentum upon an arbitrary axis (choose z-axis) is then
given by 𝑚 ℎ⁄2. If a magnetic field B is applied, this degeneracy is broken due to nuclear
Zeeman splitting. The most common nuclide for nuclear magnetic resonance (NMR) is
1H

which has a nuclear spin quantum number of 1/2 and subsequently two levels: m =

+1/2 or -1/2. In the case where B is aligned with the z-axis, the energy gap resulting from
this Zeeman splitting is

∆𝐸 =

𝛾ℎ𝐵
2𝜋

where  is the gyromagnetic ratio, which is 42.58 MHz/T for 1H. Most nuclei have a positive
gyromagnetic ratio ( > 0) while electrons and a few nuclei (e.g.,

15N)

have a negative

gyromagnetic ratio ( < 0). A depiction of this splitting is shown in figure 1.1 for both 1H
and

15N,

which are both spin 1/2 nuclei, though the gyromagnetic ratio of 1H is ~10x

greater than that of 15N.

3

Figure 1.1. Zeeman splitting for two example nuclei. The gyromagnetic ratio of 1H is ~10x
greater than that of 15N, resulting is ~10x splitting in energy for the same magnetic field
strength.

For a system at thermal equilibrium with  > 0, the relative populations for the high and
low energy conformations can be described by the ratio
𝑁𝑎𝑙𝑖𝑔𝑛𝑒𝑑
𝑁𝑎𝑛𝑡𝑖−𝑎𝑙𝑖𝑔𝑛𝑒𝑑

= 𝑒

∆𝐸⁄
𝑘𝑇

where Naligned and Nanti-aligned refer to the populations of spins in each state, k is the
Boltzmann constant, and T is the absolute temperature. There are more spins in the lower
energy state (aligned) than in the higher energy state (anti-aligned) and this population
difference results in a net magnetization that is parallel to the applied magnetic field. This
is the source of MR signal and is extremely small (on the order of ppm) at biologically
relevant temperatures and currently accessible magnetic field strengths.
The resonance energy can also be expressed as a function of frequency of precession
4

𝐸 = 2𝜋ℎ𝜔0
where 0 is the Larmor frequency, which is then proportional to the magnetic field by the
relationship 0 =- B0. If a radiofrequency (RF) pulse is applied at the Larmor frequency
for an appropriate length of time, oriented perpendicular to the applied magnetic field (B0),
the net magnetization will nutate into the transverse plane, as shown in figure 1.2 A. Once
the RF pulse is turned off, the ensemble of spins representing the net magnetization will
then precess in the transverse plane. However, microscopic fluctuations in the local
magnetic fields will result in the ensemble of precessing spins gradually losing their phase
coherence such that the net transverse magnetization will decay. If a detector or receiver
coil is placed in the transverse plane, the precessing magnetization will induce a voltage
in this coil of the form shown in figure 1.2 B. This time-domain oscillating voltage signal,
known as the free induction decay (FID), is then digitized and Fourier transformed to
obtain the MR signal.

5

Figure 1.2. Illustration of free induction decay. Effective transverse relaxation can be
characterized by A) nutating the equilibrium net magnetization into the xy-plane wherein
the spins precess about the applied magnetic field (B0) and dephase. Placement of a
receiver coil in the xy-plane generates an MR signal of the form in B) which is
characterized by the effective transverse relaxation rate constant, R2*.

The signal decay of the FID can be characterized by the effective transverse relaxation
rate constant (R2*) which is the superposition of two mechanisms, homogeneous and
inhomogeneous broadening. Homogeneous broadening is due to high frequency
microscopic fluctuations within the magnetic field and is characterized by the transverse
relaxation rate constant (R2), whereas inhomogeneous broadening is due to low
frequency macroscopic variations in the magnetic field due to magnetic susceptibility
effects or inhomogeneity in the static magnetic field.

6

Longitudinal relaxation describes the process by which the perturbed net magnetization
will return to thermal equilibrium via stochastic spin flips (-1/2  +1/2) due to thermalenergy-driven molecular motion. The applied magnetic field, B 0, biases these otherwise
random fluctuations so that over time the net magnetization returns to the equilibrium
condition where it is aligned with the applied field. To visualize this relaxation process, we
can iteratively invert the net magnetization with an RF pulse, wait some delay period t,
and then rotate the net magnetization into the transverse plane with another RF pulse to
generate an MR signal. Before the next iteration, an additional delay follows signal
collection to allow the sample to return to thermal equilibrium. This iterative process is
known as the Inversion Recovery (IR) experiment and is shown in figure 1.3 A. Plotting
the collected MR signal amplitude against the delay time between RF pulses yields a
recovery curve, shown in figure 1.3 B, which is characterized by the longitudinal relaxation
rate constant (R1).

7

Figure 1.3. Illustration of longitudinal relaxation. Longitudinal relaxation can be
characterized by A) perturbing the equilibrium net magnetization and measuring the
amplitude of the net magnetization after a delay period (t). The inversion recovery
experiment, shown here, is one method for characterizing longitudinal relaxation, which
generates an MR signal of the form shown in B) which is characterized by the longitudinal
relaxation rate constant, R1.

8

1.2.2 Oxygen MR Effects
The measured R1 of a sample can be affected by contrast agents, both endogenous and
exogenous. Exogenous MR contrasts are usually gadolinium-based complexes in which
the strongly paramagnetic gadolinium atom, with its 7 unpaired electrons, interacts with
nearby water molecules via dipole-dipole interactions, enhancing the longitudinal
relaxation (increased R1) of the protons. Similarly, O2 is an endogenous contrast agent,
though a much weaker agent due to its being only slightly paramagnetic. A heavily
exaggerated illustration of the relaxation enhancement effect due to the presence of O2
upon longitudinal relaxation is shown in figure 1.4. This relaxation enhancement effect
upon the measured R1 can then be expressed with the following relationship
R1 =R1,0 +r1 *pO2
in which R1,0 is the longitudinal relaxation rate constant in the absence of O 2, r1 is the
longitudinal relaxivity of O2, and pO2 is the partial pressure of oxygen. The relaxivity of
any contrast agent is a complex factor, dependent upon dipolar and scalar interactions
(which, in turn, are magnetic field strength dependent) and correlation times (dependent
upon motion factors, e.g., rotation and exchange rates)[16, 17]. Precise determination of
R1,0 and r1 would enable pO2 to be directly quantified from R1 measurements.

9

Figure 1.4. Illustration of 1H longitudinal relaxation of water without oxygen (solid blue)
and with oxygen (dashed red). The relaxation enhancement due to O 2 is heavily
exaggerated in this example.

Even without precise knowledge of these constants in vivo, R1-based methods can be
used in conjunction with inhaled breathing gases having variable O 2 content to drive
tissue pO2 changes[18, 19]. Variations in measured R1 are then interpreted as changes
in tissue pO2.
As stated previously, BOLD MRI derives contrast from changing concentrations of oxyand deoxyhemoglobin within the vasculature[14, 20]. Oxyhemoglobin has no unpaired
electrons and is weakly diamagnetic whereas deoxyhemoglobin has 4 unpaired electrons
and is paramagnetic[21]. The presence of deoxyhemoglobin therefore induces local
magnetic field distortions, creating magnetic susceptibility differences between the
vasculature and the surrounding tissue. These local field distortions induce more rapid
dephasing of spins in the transverse plane, thereby increasing R 2* (and also R2) in the
surrounding region. BOLD MRI, therefore, is another method for mapping variations of in
10

vivo oxygenation, with changes in R2* directly proportional to

changes in

deoxyhemoglobin.

1.2.3 Placenta
The placenta, despite playing an extremely vital role in maintaining the health of both
mother[22, 23] and fetus[24-26], remains a poorly characterized organ. This is, in part,
due to the temporary nature of the placenta and ethical barriers to studying pregnant
women. Murine placenta is a good model for the human placenta, with an analogous
layered structure and method for exchange of constituents between maternal and fetal
blood supplies[27, 28].
The placenta is responsible for maintaining fetal homeostasis through functions such as
facilitating exchange of nutrients, respiratory gases, and wastes; creation and distribution
of numerous hormones; and providing an immunological barrier between mother and
fetus. Placental dysfunction can manifest in many forms including pre-eclampsia (PE)[29,
30], intrauterine growth restriction (IUGR)[31], and infection with TORCH pathogens[32]
- which are characterized by the ability to cross and infect the placenta. In general, the
best place for a developing fetus to be is in utero. However, in cases of placental
dysfunction, wherein the most common form of treatment is early delivery, information
regarding the level of placental function could help to determine optimal timing. MR
methods could potentially provide non-invasive and reliable biomarkers of placental
function towards this end.

11

1.3 Dissertation Overview
In this dissertation, Chapters 2 – 3 focus on quantitative longitudinal relaxation methods,
using both preclinical in vivo and in vitro data to investigate the optimal signal model and
probe physiologic confounds to an R1-based tool for pO2 quantification.
Chapter 2 focuses on the problem of proper signal model selection and the use of
Bayesian probability theory-based methods to determine the optimal choice for
quantitative measurements. Longitudinal relaxation measurements collected in both in
vivo rat brain and in vitro crosslinked bovine serum albumin (xBSA) samples were used
to determine the most probable model from a pool of five potential signal models.
Chapter 3 deals with physiologic confounds to an R 1-based pO2 quantification method
using xBSA as a tissue surrogate. Sample temperature, pH, and protein concentration
were varied to determine their affects upon R 1 and the direct relationship between pO2
and R1 is quantified.
Chapters 4 – 5 then focus on investigating placental development and function in mouse
models of insufficiency and infection with MRI. Placental volume, R 1, and R2* were
measured at two time points in late gestation to assess placental growth and function.
Furthermore, a gas challenge was employed at each time point to assess the placental
response to environmental changes.
Chapter 4 employs two established mouse models of common placental disorders in
human pregnancy, PE and IUGR, to investigate how these disorders affect placental
development and function in late gestation, with respect to healthy controls.

12

Chapter 5 investigates the effects of Zika virus (ZIKV) infection and hydroxychloroquine
(HCQ) treatment upon murine placental development and function in late gestation. This
work was performed in collaboration with Dr Indira U Mysorekar and Brooke Liang at
Washington University in St Louis School of Medicine.
Finally, chapter 6 closes the dissertation with a summary of the specific accomplishments
of these studies and a brief discussion of future studies which are beyond the scope of
this work.
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Chapter 2: Bayesian Modeling of MR
Data Determines the Most Probable
Model1
2.1 Introduction
Essentially all data analysis employs a data model (or data representation), either
explicitly or implicitly. Generally, the data are considered to be the sum of the signal plus
noise and it is the estimated signal model parameters that are of primary interest. In the
ideal case, the underlying principles governing the measurement protocol and the signal
response are known and form the basis of the signal model. Often, however, this is not
the case and there exists a cohort of competing signal models from which to choose. This
may be because the underlying principles are not fully known or because the underlying
principles dictate a signal model that is too complex for meaningful comparison to data
that are insufficiently informative and, thus, simplified models based on the full complex
model must be considered. In either case, the analyst is faced with the model selection
problem, specifically, choosing which of a cohort of competing signal models best
represents the data, without “over fitting” (i.e., fitting the noise).
Bayesian probability theory based model selection provides the optimal answer to this
challenge. Bayesian analysis is “optimal” in the sense that other methods can approach,
but not surpass, the Bayesian result. To determine the optimal model amongst a cohort

1All

contents in this chapter have been published in Meinerz K, Beeman SC, Duan C, Bretthorst GL,
Garbow JR, Ackerman JJH. Bayesian Modeling of NMR Data: Quantifying Longitudinal Relaxation in
Vivo, and in Vitro with a Tissue-Water-Relaxation Mimic (Crosslinked Bovine Serum Albumin). Appl Magn
Reson. 49(1):3-24. (2018). doi: https://doi.org/10.1007/s00723-017-0964-z
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of competing models, it is necessary to balance the degree of accuracy to which the
model recapitulates the data (the goodness of fit, characterized by the residuals) against
the number of free parameters in each model (the complexity). Conceptually, the law of
parsimony, or Occam’s razor, achieves such balance, to wit, “Plurality must not be posited
without necessity”, i.e., amongst competing hypotheses, the simplest is best. Occam’s
razor is implicit in Bayesian probability theory. Indeed, Cox’s theorem [1] and its further
elaboration by Jaynes [2, 3] states that Bayesian probability theory is the optimal method
for making quantitative inference about data (i.e., optimally balancing model goodness of
fit against model complexity).
In brief, Bayesian probability theory quantifies the probability for a model/hypothesis,
described by a posterior probability distribution, given the evidence (data) and all prior
information about the system. In a qualitative sense, the posterior probability for a model
is inversely related to the aggregate calculated uncertainty over all parameter estimates
in a given model. (A more quantitative description of posterior probabilities is provided in
Methods.) This qualitative description is useful, in that it highlights the intrinsic penalties
associated with: (i) the evidence – uncertainty in the evidence, in the form of noisy and/or
sparse data, propagates into calculated posterior probability distributions, and (ii) the
model/hypothesis – increased parameterization/complexity must result in substantially
reduced aggregate uncertainty for a more complex model to be favored (satisfaction of
Occam’s razor).
MRI pulse sequences that leverage relaxation properties (e.g., T 1, T2, T2*) of the tissue
water 1H magnetization, i.e., that yield a relaxation-dependent signal-intensity (relaxationdependent “contrast”), form the foundation of a wide range of important research and
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clinical MRI protocols. Recently, a number of MRI protocols have been reported that seek
to exploit the effect of dissolved oxygen (O2, paramagnetic) on the longitudinal relaxation
of tissue water, thereby providing image contrast related to tissue oxygen content [4-7].
However, water relaxation in tissue is complicated by competing mechanisms (e.g.,
magnetization transfer) [8-11] and confounds (e.g., blood flow) [4] and, while the MRI
literature is dominated by monoexponential relaxation modeling, such an approach is
oversimplified.
Our interest in quantifying tissue water longitudinal relaxation stems from the possibility
of creating images in which voxel intensities reflect the dissolved O2 content. Molecular
oxygen, O2, is slightly paramagnetic and, thus, acts as a relaxation agent, albeit with a
small relaxivity (mM-1sec-1). The underlying question is then, “Can we make tissue water
longitudinal relaxation measurements of sufficient accuracy and precision so as to
quantify the content of dissolved O2”? The two principal tissue water relaxation
mechanisms that compete with dissolved paramagnetic O2 are: (i) magnetization transfer
(through-space and chemical exchange) with the tissue’s “macromolecular matrix” and
(ii) blood flow, which can bring equilibrium magnetization into the selected image slice.
The “apparent” relaxation effects of blood flow can be largely mitigated by appropriate
choice of pulse-sequence and are not dealt with here. However, to explore the effects of
magnetization transfer on tissue water relaxation data and modeling thereof, we have
employed cross-linked BSA (x-BSA) as a tissue mimic, one that exhibits strong
magnetization transfer effects but, of course, none of the confounds introduced by blood
flow. Given this tissue mimic, the question is then how to best model the relaxation data,
the model selection challenge.
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Biophysical modeling of tissue water longitudinal relaxation has been a topic of
investigation for decades. A monoexponential function is the simplest and most
commonly used relaxation model [4, 12, 13]. Use of this model assumes that there
effectively exists a single, uniform population of water molecules (extreme narrowing) that
can be characterized by a single longitudinal relaxation rate constant. Some have
modeled tissue water longitudinal relaxation as a biexponential function, with two distinct
(“slow” and “fast”) relaxation populations [8, 10]. However, the assumption of two
relaxation populations is undoubtedly a simplification and the heterogeneity of tissue
microstructure has led others to model relaxation based on a pseudo-continuous
distribution of relaxation populations, each with a unique relaxation rate constant [14].
The stretched exponential characterizes such a system with a single relaxation rate
constant and a “stretching” parameter, , which describes, empirically, the unknown
distribution of relaxation populations. Alternatively, the distribution can be explicitly
assumed in the model, with Gaussian [15] and gamma [15] functions serving as the most
common distributions.
Bayesian model selection is broadly applicable to a wide range of NMR data-analysis
problems when a selection from amongst a cohort of competing signal models must be
made. In the present paper, we illustrate the use of Bayesian probability theory for datadriven model selection using longitudinal relaxation data obtained in vivo (mouse brain
white matter) and in vitro with a tissue surrogate (xBSA). Water 1H magnetization
relaxation data were acquired with a high signal-to-noise ratio (SNR) and high sampling
density (regarding post inversion delay times, TIs) to compare amongst a cohort of
competing, semi-empirical relaxation models under near ideal circumstances. SNR and
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sampling density were degraded in these same datasets to examine the impact of data
quality on “optimal” (most probable) relaxation model selection and derived parameter
estimates. As the data quality decreases, becoming less informative, complex models
become less probable and simpler models are preferred, a quantitative, statistical
(probabilistic) manifestation of Occam’s razor.

2.2 Methods
2.2.1 Phantom Preparation and Data Acquisition
Samples of cross-linked 15% (by weight) bovine serum albumin (xBSA) were prepared
by diluting a 30% BSA solution (Sigma Aldrich, St. Louis, MO, USA) using phosphate
buffered saline (PBS, pH 7.4). Samples were cross-linked using a 2.5% (by volume)
solution of 50% glutaraldehyde (Electron Microscopy Sciences, Hatfield, PA, USA).
Samples were stirred with a spatula for one minute and then placed in the refrigerator
(~4oC) for two days. Four cylindrical pieces of xBSA were then extruded and each was
placed into a 5 mm, susceptibility-matched, symmetrical NMR microtube (Shigemi Inc,
Allison Park, PA, USA) and maintained at 37C for ~24 hours prior to data acquisition.
1H

NMR relaxation experiments were performed on a 500-MHz (11.74 T) Agilent/Varian

high-resolution NMR spectrometer. Most longitudinal relaxation data were collected using
a Modified Fast Inversion Recovery (MFIR) pulse sequence [16], as shown in Figure 2.1A.
Acquisition parameters were: 10,000 Hz bandwidth, 2,500 complex data points, water 1H
linewidth ~60 Hz, 96 exponentially spaced inversion delay times (TI) ranging from 5 ms
to 7.5 s, and 96 exponentially spaced wait times (W) ranging from 8.495 s to 1 s. Values
of TI and W were chosen such that the total repetition time (TR = W + TI) was a constant
value of 8.5 s. Four phase-cycled transients were collected for each TI; short, square, RF
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pulses were employed for inversion (1 ~22 s; 180 degrees) and readout (2 ~1.5 s; 10
degrees); and two steady-state (‘dummy scan’) acquisitions were utilized. A 1-ms crusher
gradient was applied following the inversion pulse to suppress any residual transverse
magnetization arising from imperfect inversion. Relaxation data for each of the four
samples were acquired in triplicate, resulting in twelve total datasets.
A separate set of experiments was performed to compare data acquired with the MFIR
pulse sequence to data acquired with the standard Inversion Recovery (IR) pulse
sequence under two different conditions. Acquisition parameters for the MFIR experiment
were: 10,000 Hz bandwidth, 2,500 complex data points, water 1H linewidth ~150 Hz, 64
exponentially spaced inversion delay times (TI) ranging from 5 ms to 7.5 s, and 64
exponentially spaced wait times (W) ranging from 8.495 s to 1 s. Values of TI and W were
chosen such that the total repetition time (TR = W + TI) was a constant value of 8.5 s.
Four phase-cycled transients were collected for each TI; square, RF pulses were
employed for inversion and readout; and five steady-state (‘dummy scan’) acquisitions
were utilized. Acquisition parameters for the IR experiment were: 64 exponentially spaced
inversion delay times (TI) ranging from 5 ms to 7.5 s, and a relaxation delay time (time
following the 2 readout pulse) of 10 s. All other parameters were the same as the MFIR
experiment.
For these comparative experiments, two sets of square, RF pulse widths were utilized,
designated as either “short” (broad excitation bandwidth) or “long” (narrow excitation
bandwidth). For the short pulse width condition, the inversion pulse 1 ~22 s (180
degrees) and the observation pulse 2 ~11 s (90 degrees). For the long pulse width
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condition, the inversion pulse 1 ~1.3 ms (180 degrees) and the observation pulse 2 ~650
s (90 degrees). All relaxation data (MFIR vs. IR; short vs. long pulses) were acquired in
interleaved fashion in triplicate on a single sample, resulting in three replicate datasets
for each of the four protocols.

Figure 2.1. A) Schematic illustration of the Modified Fast Inversion Recovery (MFIR)
pulse sequence [16]. RF refers to the radio frequency output and signal acquisition: 1 is
a 180 degree (π) inversion pulse, 2 is a 10 degree magnetization sampling pulse. Gcrush
represents the magnetic field gradient pulse applied to destroy (crush) any transverse
magnetization coherence produced following a non-ideal 1 inversion pulse. TI is the
variable time from the inversion pulse to the magnetization sampling pulse, W is the
waiting time, and TR is the time to repetition. TR is the sum of TI and W and is a constant
value. B) Schematic illustration of the Inversion Recovery Point Resolved Spectroscopy
(IR-PRESS) pulse sequence. A non-slice-selective inversion pulse is followed by a
PRESS readout sequence, employing weak diffusion sensitizing gradients to destroy
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transverse magnetization coherence within the vasculature (i.e., to suppress signal from
flowing blood).

2.2.2 In Vivo Subject Preparation and Data Acquisition
All animal experiments were approved by the Washington University Institutional Animal
Care and Use Committee. In vivo 1H relaxation data were collected on a 4.7-T smallanimal MRI system (Agilent Technologies, Santa Clara, CA, USA) using a laboratorybuilt, actively decoupled, volume-transmit/surface-receive coil pair. One 200 g female
Sprague Dawley Rat was anesthetized with 1% isoflurane in 100% O 2, and body
temperature was monitored with a rectal thermometer and maintained at 37 oC via the
combination of circulating warm water and warm air. An Inversion Recovery Point
RESolved Spectroscopy (IR-PRESS) sequence selecting a 1.6 x 1.6 x 1.6 mm3 voxel was
modified to minimize apparent relaxation contributions from blood flow, as shown in
Figure 2.1B. Specifically, the sequence employed: (i) a non-slice-selective inversion
pulse, followed by 8-gauss/cm crusher gradients applied along all three axes to destroy
any transverse magnetization created by an imperfect inversion pulse, and (ii) weak,
diffusion-sensitizing gradients applied along all three axes (total b = 100 s/mm 2) to destroy
any transverse coherence of blood-water 1H magnetization flowing into the PRESS voxel
via the vasculature. Acquisition parameters were: 4006 Hz bandwidth, 2048 complex data
points, water 1H linewidth ~11 Hz, 128 exponentially spaced inversion delay times (TI),
ranging from 0.0075 sec to 4.25 sec, effective echo time (TE) of 20 ms and a repetition
time (TR) of 5 sec. Relaxation data were collected in triplicate from the corpus callosum
(white matter).
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2.3 Mathematical Models
The monoexponential relaxation model is given by:
𝑀𝑧 (𝑡) = 𝐴 ∗ exp(−𝑡 ∗ 𝑅1 ) + 𝐶,

[2.1]

in which Mz(t) is the net longitudinal magnetization, A is a constant amplitude, t is time
(corresponding to the inversion delay time, TI, in our experiments), R 1 is the longitudinal
relaxation decay rate constant, and C is a constant offset. Similarly, the biexponential
model can be written as:
𝑀𝑧 (𝑡) = 𝐴 ∗ [𝐹 ∗ exp(−𝑡 ∗ 𝑅1,𝑓𝑎𝑠𝑡 ) + (1 − 𝐹) ∗ exp(−𝑡 ∗ 𝑅1,𝑠𝑙𝑜𝑤 )] + 𝐶,

[2.2]

in which F is the fraction of the total amplitude of the “fast” relaxation component and (1F) is the fraction of the “slow” relaxation component. The stretched monoexponential
relaxation model is described by inserting a fractional power law into the monoexponential
function:
𝑀𝑧 (𝑡) = 𝐴 ∗ exp(−𝑡  ∗ 𝑅1 ) + 𝐶,

[2.3]

in which  is the stretching exponent.

Two additional models were considered: A Gaussian-type (normal) distribution function
for R1 [15] and an R1 distribution function based on the gamma distribution [15]. The
Gaussian-type function is given by:
2

𝐴 ∗ exp (−
𝑃(𝑅1 ) = {

(𝑅1 −𝑅1,𝑚𝑎𝑥 )
2 2

) + 𝐶, 𝑅1 > 0

0, 𝑅1 < 0
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,

[2.4]

in which A is a normalization constant:


𝐴−1 = √2 [1 +  (

𝑅1,𝑚𝑎𝑥

√2

)] .

[2.5]

R1,max corresponds to the peak of the distribution,  is the standard deviation of the
distribution (2 is the variance),  is the error function, and C is constant offset. The
modified gamma-type distribution is of the form:

𝑎

𝑀𝑧 (𝑡) = 𝑀𝑧 (𝑡 = 0) ∗ (𝑎+𝑡∗𝑅

1,𝑚𝑎𝑥

(𝑎+1)

)

+ 𝐶,

[2.6]

in which Mz(t=0) is the initial net longitudinal magnetization, a is a shape parameter, and
C is a constant offset.

2.2.4 Bayesian-Based Model Selection
The posterior probability for each of the relaxation models was calculated using Bayes’
theorem [2, 3]:

𝑃(𝑀|𝐷𝐼) =

𝑃(𝑀 |𝐼 )𝑃(𝐷|𝑀𝐼)
𝑃(𝐷|𝐼)

,

[2.7]

in which P(M|DI) is the posterior probability for a model M, given data D, and prior
information I; P(M|I) is the prior probability for a model given the prior information; P(D|MI)
is the probability for the data, given the model and the prior information; and P(D|I) is the
direct probability for the data, given the prior information. To calculate the posterior
probability for a model given the data and the prior information, the direct probability for
the data, given the model and the prior information, must first be calculated. As an
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example, the stretched exponential model has two calculated parameters,  and R1, such
that the expansion of P(D|MI) is of the form:
𝑃(𝐷|𝑀𝐼) = ∫ 𝑑𝛼𝑑𝑅1 𝑃(𝛼𝑅1|𝑀𝐼)𝑃(𝐷|𝛼𝑅1 𝑀𝐼),

[2.8]

in which P(R1|MI) is the joint prior probability for  and R1, given the model and the prior
information, and P(D|R1MI) is the direct probability, given the parameters, model, and
prior information.
In Bayesian probability theory, the entire multidimensional integral or “hypervolume”
covering the full range of possible parameter values must be computed and contributes
directly to P(M|DI). Every hypervolume is computed by integrating the joint prior
probability for the parameters weighted by the direct probability of the data, given the
parameters. Using in-house developed Bayesian analysis software (available for free
download at bayes.wustl.edu) that utilizes Markov-chain Monte Carlo simulations to
approximate the high-dimensional integrals, the posterior probabilities for each of the
models, and their associated parameters, were calculated.
In each case, the results shown are from the joint analysis of either three (in vivo) or
twelve (xBSA) replicate datasets. Generally, in a joint analysis, some of the model
parameters are assigned as common (common valued) to all members of the full set of
replicate datasets and some are assigned as unique (uniquely valued) to each member
of the full set of replicate datasets. In the joint analysis employed herein, the reported
model parameters (e.g., relaxation rate constants) were taken as common to all members
of the full set of replicate datasets. The values of each of the model’s common parameters
that best represented the full set of replicate datasets were taken as optimal (most
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probable). We note that Bayesian joint analysis is distinct from averaging either the
datasets or the parameters estimated from each dataset. In Bayesian joint analysis, the
probability distributions weight the parameter estimates toward those favored by the more
informative (e.g., higher signal-to-noise, fewer artifacts) members of the full set of
replicate datasets. Herein, data quality was relatively uniform (equally informative) across
all replicate datasets.
Within the Markov-chain Monte Carlo simulation, 50 parallel simulations were performed
to sample the posterior probabilities for the model and its parameters. Simulated
annealing brought the 50 simulations into steady-state equilibrium, at which time 50
samples from each of the 50 simulations were drawn. Thus, in total, 2,500 parameter
samples were used to characterize the posterior probability density distributions for the
models and their parameters.
Herein, the peak (maximum) of the relevant posterior probability density distributions are
taken as the optimal (most probable) parameter estimates. Alternatively, one could
choose the mean of the distribution. For symmetrical distributions, these choices are,
obviously, equivalent. Uncertainty in a given parameter estimate is taken as ± the
standard deviation (square root of the variance) of the distribution. More precise
parameter estimates are characterized by narrower posterior probability density
distributions.

2.2.5 Data Truncation, Sampling Density Reduction, and Noise
Addition
As will be described, Bayesian model selection heavily favored the biexponential model
for the xBSA longitudinal relaxation data (vide infra). In this case, the fast relaxation
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component is characterized by a rate constant that is two orders of magnitude greater
than that of the slow relaxation component, but has an amplitude that is only 2% that of
the slow component. As a consequence, the available dynamic range and sampling
density is limited, until the slow component dominates the signal. In practice, accurate
characterization of this small-amplitude fast component will often be impractical due to
time constraints and/or insufficient SNR and further, might be uninteresting for some
experiments (e.g., contrast agent quantification, when it is expected that the relaxation
modulating effects of the agent will only be observable on the slow rate constant). To
simulate a potential time saving inversion recovery experiment, we truncated our datasets
to include only data points associated with the slow component. Based on estimation of
the relaxation rate constant for the fast relaxation component (R1,fast = 1/T1,fast) from the
joint analysis of twelve full, 96-TI-value datasets, the first 45 TIs were removed, obviating
information on relaxation occurring during the period of 5 x T1,fast, and the smallest TI was
then approximately 160 ms.
To more accurately mimic the in vivo case, in which both acquisition time and SNR may
be limited, these twelve truncated xBSA relaxation datasets (i.e., minimum TI ~160 ms,
data reflecting only the slow relaxation component) were further modified. (i) To simulate
the acquisition-time-limited case, the sampling density was made increasingly sparse by
iteratively removing every other data point, until only seven TIs remained. Bayesian joint
analysis was then performed on the full datasets (51 TIs), intermediate-size datasets (26
TIs), and small-size datasets (7 TIs). (ii) To explore the effect of limited SNR, Gaussiandistributed noise (zero mean, standard deviation of one) was added to each of the twelve
full (51 TI values) datasets. Prior to the addition of noise, these in vitro xBSA samples
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exhibit very high SNR (SNR = 600), defined throughout as the signal amplitude at the
longest TI value divided by the root mean square noise value. Added Gaussiandistributed noise reduced the SNR to an intermediate value (SNR = 100) and a lower
value (SNR = 25) typical of in vivo relaxation datasets. Bayesian joint analysis was then
performed on the full datasets (51 TIs) at each of the three SNRs. (iii) To determine the
combined effects of limited data sampling density and limited SNR on parameter
estimation, Gaussian-distributed noise was added to reduce the SNR to an intermediate
value (SNR = 100) followed by the reduction of the sampling density to achieve the full
datasets (51 TIs), intermediate-size datasets (26 TIs), and small-size datasets (7 TIs).
Bayesian joint analysis was then performed on the twelve, intermediate SNR valued
datasets at each of the three sampling densities.

2.3 Results
As shown in Figure 2.2, Bayesian joint analysis of the twelve full (96 TIs) relaxation
datasets, collected using the xBSA sample, selected the biexponential as the heavily
favored model. However, residuals from both biexponential and monoexponential models
display clear, smooth oscillations, characteristic of under-parameterization, suggesting
that the biexponential model does not fully represent xBSA relaxation data characterized
by both high signal-to-noise, SNR = 600, and high sampling density, 96 TIs (Figure 2.2B).
The root mean squared (RMS) of the residuals of the biexponential model (0.002) was
substantially less than that of the monoexponential model (0.011). The resulting
parameter estimates from this model are R1,slow = 0.4164 ± 0.0003 s-1 and R1,fast = 33.6 ±
1.1 s-1 (Figure 2.2C). The fractions of the total amplitude corresponding to the slow and
fast relaxation components are 0.9801 ± 0.0003 and 0.0199 ± 0.0003, respectively. (Note,
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the amplitude and the rate constant of the fast relaxation component will depend upon
the extent of magnetization transfer produced by the relaxation measurement protocol
(vide infra).) When the monoexponential model is used, R 1 is calculated to be 0.4290 ±
0.0008 s-1. For comparison, parameter estimates from both the favored biexponential
model and the monoexponential model can be found in Table 2.1.

Figure 2.2. A) Representative full, 96 TI relaxation dataset (black diamonds: signal
intensity vs. TI) from the xBSA phantom, fit with the heavily favored biexponential model
(gray line). B) The resulting residuals from both the biexponential model (solid black line)
and the monoexponential model (dashed black line) are plotted against the “inversion
number” (i.e., the 96 TI increments arranged linearly by increment number). The
biexponential fit has a resulting root mean square (RMS) residual of 0.002, whereas the
monoexponential fit has an RMS residual of 0.011. C) Bayesian-estimated posterior
probability densities from joint analysis of all twelve xBSA relaxation datasets for (i) the
rate constant for the slow component from the biexponential fit (solid black line), peaking
at R1,slow = 0.4164  0.0003 s-1 and (ii) the rate constant from the monoexponential fit
(dashed black line), peaking at R1,mono = 0.4290  0.0008 s-1; inlaid is the rate constant
for the fast component from the biexponential fit (dotted black line), peaking at R 1,fast =
33.6  1.1 s-1.

The biexponential model was also heavily favored by Bayesian joint analysis of three full
(128 TIs) in vivo datasets collected within the corpus callosum (white matter) of rat brain.
The residuals from both the favored biexponential fit and the monoexponential fit show
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oscillations (Figure 2.3B) that are similar to those seen with the xBSA sample. Similar to
the xBSA sample, the RMS of the residuals of the biexponential model (0.007) was less
than that of the monoexponential model (0.008), a difference of ~15%, and the resulting
parameter estimates for the favored model are R1,slow = 0.681 ± 0.003 s-1 and R1,fast = 28.5
± 2.9 s-1 (Figure 2.3C). The fractions of the total amplitude associated with the slow and
fast relaxation components are 0.973 ± 0.001 and 0.027 ± 0.001, respectively. By
comparison, when the monoexponential model is used, the derived rate constant is R 1 =
0.708 ± 0.003 s-1. Parameter estimates from both models can be found in Table 2.1.

Figure 2.3. A) Representative full, 128 TI dataset (black diamonds) from in vivo corpus
callosum in rat brain, fit with the heavily favored biexponential model (gray line), plotted
against the time from the inversion pulse. B) Resulting residuals from the favored
biexponential fit (solid black line) and the monoexponential model (dashed black line) are
plotted against the “inversion number” (i.e., the 128 TI increments arranged linearly by
increment number). The biexponential fit achieves an RMS residual value of 0.007,
whereas the monoexponential fit achieves a value of 0.008. C) Bayesian-estimated
posterior probability densities from joint analysis of all three in vivo corpus callosum
relaxation datasets for (i) the rate constant corresponding to the “slow” relaxation
component from the favored biexponential fit (solid black line), peaking at R1,slow = 0.681
 0.003 s-1 and (ii) the rate constant from the monoexponential model (dashed black line),
peaking a R1,mono = 0.708  0.003 s-1; inlaid is the rate constant corresponding to the “fast”
component from the favored biexponential model (dotted black line), peaking at R1,fast =
28.5  3.0 s-1.
31

Table 2.1: Rate Constants and RMS Residuals from xBSA Phantom and in Vivo Joint
Analyses

Following truncation of the xBSA datasets as described in Methods, twelve datasets,
corresponding to the slow relaxation component (51 Tis; Figure 2.4), were analyzed jointly
and the stretched exponential model was found to be heavily favored. Residuals from the
stretched exponential model and the monoexponential model (Figure 2.4B) show similar
oscillatory patterns as in the full xBSA relaxation dataset, suggesting that neither model
is able to characterize fully the longitudinal relaxation of the sample. However, it is evident
from the RMS residuals that the stretched exponential model (0.0007) achieves a better
goodness of fit than the monoexponential model (0.0021). The resulting parameter
estimates from this model are R1 = 0.4197 s-1 ± 0.0002 s-1 (Figure 2.4C) with  = 0.9759
± 0.0004. When the monoexponential model is used, the derived rate constant R 1 is found
to be 0.4157 ± 0.0003 s-1.
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Figure 2.4. A) Representative truncated dataset from xBSA phantom illustrating the
“slow” relaxation component (black diamonds), fit with the heavily favored stretched
exponential model (gray line), plotted against the time from the inversion pulse. B) The
resulting residuals from the heavily favored stretched exponential model (solid black line)
and the monoexponential model (dashed black line) are shown against the “inversion
number” (i.e., the 51 TI increments arranged linearly by increment number). The stretched
exponential fit achieves an RMS residual value of 0.0007, whereas the monoexponential
fit achieves an RMS residual value of 0.0021. C) Bayesian-estimated posterior probability
densities from joint analysis of all twelve truncated datasets for the rate constants from (i)
the favored stretched exponential (solid black line), peaking at R1 = 0.4197  0.0002 s-1
and (ii) the monoexponential model (dashed black line), peaking at R 1 = 0.4157  0.0003
s-1.

Modification of the truncated (slow relaxation component only) xBSA datasets to more
closely approach the in vivo case with respect to either limited sampling density, SNR, or
the combination thereof, leads to Bayesian-estimated posterior probability densities for
the stretched exponential with respect to the number of TIs (Figure 2.5A, Table 2.2), the
SNR (Figure 2.6), and the number of TIs at decreased SNR (Figure 2.5B). In the case of
high SNR with decreasing sampling density, the resulting parameter estimates are
(Figure 2.5A) R1 = 0.4197 ± 0.0002 s-1 and  = 0.9760 ± 0.0004 for 51 TIs; R1 = 0.4197
± 0.0002 s-1 and  = 0.9759 ± 0.0006 for 26 TIs; and R1 = 0.4195 ± 0.0004 s-1 and  =
0.9769 ± 0.0013 for 7 TIs. The stretched exponential is favored in all cases. The resulting
parameter estimates in the case of high sampling density, 51 TIs, with decreasing SNR
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(Figure 2.6, Table 2.3) are R1 = 0.4197 ± 0.0002 s-1 and  = 0.9759 ± 0.0004 for SNR =
600; R1 = 0.4187 ± 0.0011 s-1 and  = 0.9746 ± 0.0035 for SNR = 100; and R1 = 0.4228
± 0.0041 s-1 with  = 0.9733 ± 0.0130 for SNR = 25. The stretched exponential model is
heavily favored for the SNR = 600 and SNR = 100 datasets, as denoted by the asterisk
(*) in the figure. For the monoexponential model (Figure 2.6C) the resulting parameter
estimates are R1 = 0.4157 ± 0.0003 s-1 for SNR = 600; R1 = 0.4145 ± 0.0010 s-1 for SNR
= 100; and R1 = 0.4185 ± 0.0035 s-1 for SNR = 25 (for which the monoexponential model
was favored). In the case of intermediate signal (SNR = 100) with decreasing sampling
density, the resulting parameter estimates are (Figure 2.5B, Table 2.2) R1 = 0.4187 ±
0.0011 s-1 and  = 0.9746 ± 0.0035 for 51 TIs; R1 = 0.4183 ± 0.0014 s-1 and  = 0.9696
± 0.0043 for 26 TIs; and R1 = 0.4179 ± 0.0015 s-1 and  = 0.9631 ± 0.0045 for 7 TIs. The
stretched exponential is favored in all cases.

Figure 2.5. Bayesian-estimated posterior probability density of the heavily favored,
stretched exponential model’s decay-rate constant, R1, (A) for the case of 51 TIs (solid
black line) peaking at R1 = 0.4197  0.0002 s-1, 26 TIs (solid gray line) peaking at R 1 =
0.4197  0.0002 s-1, and 7 TIs (dotted black line) peaking at R 1 = 0.4195  0.0004 s-1
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following truncation of the original 96 TI datasets. B) The same culled datasets as in (A)
following the addition of Gaussian-distributed noise to reduce the SNR to approximately
100. For each case, the heavily favored model is the stretched exponential and the R 1 is
found to be 0.419  0.001 s-1 for 51 TIs, 0.418  0.001 s-1 for 26 TIs, and 0.418  0.002
s-1 for 7 TIs. Each posterior probability density curve is the result of twelve jointly analyzed
xBSA relaxation datasets.

Table 2.2: Sparsity & SNR Reduction Effects Upon Parameter Estimates in xBSA
Phantom

Figure 2.6. Bayesian-estimated posterior probability densities for the cases of SNR = 600
(solid black line), SNR = 100 (solid gray line), and SNR = 25 (dotted black line) for the
“slow” relaxation component (51 TIs) following the addition of Gaussian-distributed noise.
A) The posterior probability densities for the R 1 determination, using the stretched
exponential model. The case of SNR = 600 peaks at R 1 = 0.4197  0.0002 s-1, SNR =
100 peaks at R1 = 0.419  0.001 s-1, and SNR = 25 peaks at R1 = 0.423  0.004 s-1. B)
The corresponding posterior probability densities for  in each of the three cases. When
SNR = 600,  peaks at 0.9759  0.0004; for SNR = 100,  peaks at 0.975  0.004; for
SNR = 25,  peaks at 0.97  0.01. C) The posterior probability densities for the R1
determination using the monoexponential model. The case of SNR = 600 peaks at R 1 =
0.4157  0.0003 s-1, SNR = 100 peaks at R1 = 0.415  0.001 s-1, and SNR = 25 peaks at
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R1 = 0.419  0.004 s-1. In each case, if the model used was the favored model, an asterisk
(*) accompanies the label. The heavily favored model for the SNR = 600 and SNR = 100
was found to be the stretched exponential and for the case of SNR = 25 the heavily
favored model was found to be the monoexponential.

Table 2.3: Parameter Estimates for xBSA Phantom Following SNR Reduction

* denotes favored model.

To validate methodology employed herein for quantifying relaxation, data acquired with
the MFIR protocol were compared to data acquired with the standard inversion recovery
(IR) protocol under two conditions: (i) short 90 and180 degree RF-pulses (2 and 1,
respectively), as are commonly employed with high resolution (analytical) NMR
spectrometers, herein ~10 and 20 µs, respectively; and (ii) long 90 and 180 degree RFpulses as are commonly employed with MRI scanners, herein ~650 and 1,300 µs,
respectively. Data were acquired in triplicate on a single xBSA sample, interleaving the
MFIR and IR protocols. When short pulses yielding broad excitation bandwidths were
employed, the MFIR and IR protocols resulted in essentially identical parameter estimates
for the most probable model, biexponential. When long pulses yielding narrow excitation
bandwidths were employed, the MFIR and IR protocols again resulted in essentially
identical parameter estimates for the most probable model, biexponential. Of particular
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note, however, the estimated fractional amplitude of the fast relaxation component (F)
increased markedly from ~3% with short (broadband) pulses to ~20% with long (narrow
band) pulses. Consistent with the signal-to-noise increase for the fast relaxation
component, and corresponding decrease for the slow component, the uncertainly in the
estimated R1,fast decreased and that for the estimated R1,slow increased [17]. These results
are summarized in Table 2.4.
Table 2.4: Summary of Parameter Estimates for xBSA Phantom Comparing MFIR & IR
vs. Pulse Width

2.4 Discussion
The biexponential model is heavily favored for the high SNR, high sampling density,
relaxation datasets from both the xBSA phantom and mouse brain (white matter) in vivo,
supporting the conclusion that the xBSA phantom is a good in vitro longitudinal relaxation
surrogate for tissue [8, 10]. In addition, both samples (xBSA, in vivo brain) yield derived
model parameters that have similar characteristics: (i) the relaxation rate constants
associated with the fast and slow relaxation components are well-resolved, separated by
two orders of magnitude, and (ii) the fractions of the total amplitude attributable to the fast
and slow relaxation components from the xBSA phantom and the in vivo results are
comparable. Though the in vivo and in vitro data were collected at different magnetic field
strengths – 200 MHz and 500 MHz, respectively – and, thus, the R1 values cannot be
directly compared, as expected, relaxation of the dominant component (R1,slow) at 11.74
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T vs. 4.7 T is less efficient due to reduced spectral density at the higher resonance
frequency. Finally, the residuals from the biexponential modeling of both the xBSA and in
vivo datasets show the same systematic oscillatory feature, indicating that, while the
model captures well the principal features of the signal, it does not fully characterize the
data. However, when tested against a triexponential function, Bayesian model selection
still heavily favored the biexponential model in both the in vitro and in vivo cases (data
not shown). In Bayesian analysis, each additional parameter added to a model naturally
incurs a penalty related to the posterior probability distribution of that parameter, so that
more complex models (models with more parameters) must markedly improve the
goodness of fit (e.g., chi squared) or be rejected, a manifestation of Occam’s razor.
The failure of a triexponential function to improve the modeling indicates that the penalty
associated with adding two additional parameters (a third rate constant and associated
fractional amplitude) more than offsets any resulting improvement in the goodness of fit.
The failure of the triexponential model, of course, does not preclude the use of other
models that might better describe the system. Having demonstrated that the xBSA
phantom mimics in vivo tissue longitudinal relaxation will allow us to utilize this phantom
in future experiments as a tissue surrogate to further probe the R 1 measurement as
regards modifiers of interest, e.g., pH, protein content, pO2.
As the monoexponential model is used frequently to fit longitudinal relaxation data, the
residuals and the Bayesian-estimated posterior probability distributions from the favored
model were compared with those from the monoexponential model for the full, 96 TIs,
and truncated, 51 TIs, xBSA relaxation datasets, and the in vivo datasets, 128 TIs. In all
cases, we observe a clear shift in the location of the peak (maximum probability) of the
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posterior probability distribution for the slow decay-rate constant derived with the favored
model vs. the rate constant posterior probability distribution derived from a
monoexponential fit. The monoexponential model is a relatively poor representation of
the system, lacking sufficient parameters to accurately characterize the longitudinal
relaxation, especially for the early time points (short TI values). For both the full xBSA
and in vivo datasets, the monoexponential model attempts to characterize both the fast
and slow components with a single rate constant, resulting in a skewed parameter
estimation. Attempting to fit a dataset with a model that lacks sufficient complexity may
yield a precise parameter estimate(s) that is not accurate, as seen in Figures 2.2C (full
xBSA dataset), 2.3C (in vivo dataset), and 2.4C (truncated xBSA dataset). In each case,
however, the change in the uncertainty of the estimated rate constant from the preferred
rate-constant model is insignificant compared to that derived from the less probable,
simple monoexponential model.
As noted, given its rapid decay and small fractional amplitude, it is difficult to characterize
accurately the fast relaxation component. This will be especially true in relaxation
experiments in vivo, in which acquisition time and SNR are limiting. Consequently, it is
worth considering how to collect data corresponding only to the slow component, and to
consider how doing so may affect the derived parameters. Using the resulting T1,fast from
the joint analysis of twelve full xBSA datasets with 96 TIs, the time t = 5 x T 1,fast was
calculated and the data points collected at shorter TI values were dropped (truncated)
from the dataset. In principle, at TI = 5 x T1,fast, >99% of the fast relaxation component will
have returned (decayed) to thermal equilibrium polarization so that, in effect, all of the
relaxation signal derives from the slow relaxation component. Therefore, it would seem
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logical that the favored (most probable) relaxation model describing the truncated data
would be monoexponential. Instead, however, these data were best described by the
stretched exponential model. As illustrated by the estimated parameter values shown in
Results, the stretching parameter () is very close to 1 and, therefore, the stretched model
is not far removed from a pure monoexponential. However, as shown in Figure 2.4B, even
a small change in  is enough to produce significant changes in the resulting residuals.
The RMS residual from the monoexponential fit is three times greater than that of the
stretched exponential, illustrating that the added complexity results in significantly
improved modeling of the data. In addition, the peak in the posterior probability density
for the R1 relaxation rate constant (Figure 2.4C) for the monoexponential (R1 = 0.4157 s1)

is shifted with respect to the peak of the distribution corresponding to the stretched

exponential (R1 = 0.4197 s-1). This shift is significant enough that the distributions are well
resolved, demonstrating that the choice of model does affect the accuracy of parameter
estimation. (If only the relative differences in parameter values between tissue types, and
not their true values, are important, this introduction of bias into parameter estimation may
not matter.) Thus, when attempting to quantify R 1 accurately and precisely, model
selection is necessary. When applied to a cohort of competing signal models, Bayesian
model selection can provide: (i) an avenue to make quantitative biophysical inferences
and (ii) a check against over-interpretation/over-parameterization of data. Of the five
models we tested, the biexponential and stretched exponential models best represent the
full TI datasets and the truncated datasets, respectively. However, systematic smooth
oscillations in the residuals demonstrate that these functions do not fully model the data.
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The existence of these systemic oscillations, even from the favored choice among our
cohort of five signal models, is not a limitation of Bayesian-based model selection but,
instead, is a limitation in the ability of the models used to represent the data. As described
previously, even when a more complex exponential model --a triexponential model – was
included, the biexponential model was still favored. This means the increase in
parameterization did not result in a sufficiently decreased residual so as to favor the more
complex model. To further reduce or eliminate those systemic oscillations, other signal
models will have to be explored. A model that accounts for exchange between waterrelaxation-populations, such as the Bloch-McConnell exchange model [18] or perhaps a
multi-modal R1 distribution model, such as those based on the work of Brownstein and
Tarr [19, 20] may result in a substantially improved data representation.
To select the “best” (most probable) model, Mopt, from the cohort of competing models, M
= {Mi}, the Bayesian-based algorithm seeks the highest valued posterior probability
P(M|DI), Eq. [7]. Assuming relatively uninformative model prior probabilities, P(M|I), as
employed herein, P(M|DI) is principally determined by the marginal direct probability for
the data, P(D|MI), given model M, which is inversely proportional to the aggregate
calculated uncertainty over all parameters (more formally, integration over all probability
distributions); see Eq. [8] for an example. A more complex model must result in a
significant decrease in the aggregate uncertainty to be favored over a model with fewer
free parameters, a manifestation of Occam’s razor. Examples of this are given by the
modeling residuals described in Results, as well as the RMS residual values for the
favored and monoexponential models shown in Table 2.1.
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Often, experiments are acquisition-time- or signal-to-noise-limited. To better understand
the effect of such limitations, the data corresponding to the xBSA slow relaxation
component were modified. To mimic time constraints, the xBSA datasets with 51 TIs were
truncated to reduce the sampling density within each dataset. Collecting data with all 51
TI values, which requires 20 or more minutes, represents the case of no significant time
constraints, as in, for example, the study of ex vivo tissue samples. 26 TIs, requiring
perhaps 10 minutes of data collection, represents a typical small-animal scan. Finally, the
relaxation experiment employing only 7 TIs, represents a short data-collection period, as
might be required for a clinical scan. For each of these cases, Bayesian-based model
selection was performed jointly on twelve datasets and, in each case, the stretched
exponential model was heavily favored.
The effect of decreasing sampling density, mimicking increasingly limited data-acquisition
time, on the Bayesian-estimated posterior probability distribution for the decay-rate
constant is illustrated in Figure 2.5A. As the number of TIs decreases, the posterior
probability distribution becomes broader, demonstrating that certainty in the parameter
estimation decreases with decreasing sampling density. We note that as the original
xBSA datasets were acquired under very high SNR conditions and the preferred model,
the stretched exponential, has only four parameters, the Bayesian-estimated posterior
probability distributions are narrow, even for the case of 7 TIs.
To see this effect more clearly, Gaussian-distributed noise was added to the twelve xBSA
datasets with 51 TIs to reduce the SNR to the intermediate case of SNR = 100, which
can be achieved in a single voxel in vivo MR spectroscopy (MRS) relaxation experiment,
and subsequently truncated to reduce the sampling density to 26 TIs and further 7 TIs.
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For each of these cases, Bayesian-based model selection was performed jointly on
twelve datasets and, in each case, the stretched exponential model was heavily favored.
The resulting posterior probability distributions for the rate constants are shown in Figure
2.5B. We see the same general trend as that of the high SNR case (Figure 2.5A),
broadening of the distributions as the sampling density decreases. Here, the effect is
exacerbated by the decreased SNR (SNR = 600 vs. 100).
To simulate the case in which signal-to-noise is the limiting factor, Gaussian-distributed
noise was added to the 51 TI datasets so that the SNR decreased from its original value
of 600, to an intermediate value of 100, and further down to 25, typical of an in vivo MR
imaging relaxation experiment. For the SNR = 25 case, the monoexponential model was
heavily favored, whereas the stretched exponential model was heavily favored for both
the cases of SNR = 600 and SNR = 100. The resulting Bayesian-estimated posterior
probability distributions for the decay-rate constant and alpha parameters from the
stretched exponential model are shown in Figures 2.6A and 2.6B, respectively. Figure
2.6C shows the resulting parameter estimates when the monoexponential model is used.
As the SNR decreased, the resulting posterior probability distributions become much
broader, with the standard deviation for the R1 estimation increasing by a factor of
approximately 5. It is important to note that in this case, the standard deviation is not a
measure of the spread of measured rate constants within our population. Here, the
standard deviation is a Bayesian-derived measure of the uncertainty in the calculated
parameter estimate. The added noise can be thought of as uncertainty within the data,
which is propagated through, and reflected in, the increased uncertainty of the parameter
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estimates. This means that with increased noise, the precision of the parameter
estimation decreases.
There is also a shift in the peak of the posterior probability distribution for the case of SNR
= 25 with respect to the high and intermediate SNR cases (Figures 2.6A & 2.6B, Table
2.3). This can be explained by the change in the favored model, as the result of fitting the
data with a different model introduces bias into the parameter estimation. While the
variations in the parameter estimates (shifts in positions of the peaks of the posterior
probability distributions) and uncertainties therein (changes in widths of the posterior
probability distributions) are modest as SNR and sampling density are degraded, the
trends are informative and consistent with what would be observed under more severe
degradation of data quality.
An important consideration regarding this result is that, while a SNR = 25 can be
considered low, the joint analysis of three (in vivo) and twelve (xBSA) replicate datasets,
each with different additive noise elements but the same noise power, greatly increases
the statistical power of Bayesian inference. From a frequentist point of view, assuming all
dataset members are of equal quality (i.e., equally informative), the full dataset SNR is
proportional to the square root of the number of replicate members in the dataset. Thus,
while each of the twelve replicate members of the xBSA dataset had SNR = 25, the full
dataset can be considered to have a SNR = 25 x (12) 1/2 = 87. Thus, even under conditions
in which each xBSA dataset member had SNR = 25, the joint analysis of twelve replicate
members yielded quite precise parameter estimates.
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The tissue-mimicking xBSA phantom possesses both a narrow water 1H resonance,
characteristic of a small, highly mobile, randomly reorienting molecule and a very broad
crosslinked-protein 1H resonance feature, characteristic of semi-solid macromolecules. A
short, 180-degree pulse will invert magnetization over a broad range of resonance
frequencies (e.g., 20 µs → ~5,000 Hz), thus, to first approximation, inverting both the
water and the crosslinked protein 1H magnetization. In this case, 1H magnetization
transfer between water and protein pools does not act as an efficient longitudinal
relaxation mechanism for water. A long, 180-degree pulse will invert magnetization over
a narrow range of resonance frequencies (e.g., 1.6 ms → ~600 Hz), thus, to first
approximation, inverting the water 1H magnetization while leaving the majority of the
protein 1H magnetization in the thermally equilibrated (Boltzmann) polarized state. In this
case, 1H magnetization transfer between water and protein pools acts as an efficient
longitudinal relaxation mechanism for water. The data summarized in Table 2.4 bear this
out. In the case of short (broadband) RF pulses, the fractional amplitude of the fast
relaxation component, which reflects the population of water molecules that relax via
magnetization transfer with the crosslinked protein pool, is near zero (~3%), but increases
markedly to 20% in the case of long (narrowband) RF pulses. Long RF pulses (1 - 4 ms)
are typical of in vivo MRI protocols and, thus, magnetization transfer effects will manifest
significantly in longitudinal relaxation experiments in vivo [10].
In conclusion, we have shown that xBSA displays similar longitudinal relaxation
characteristics to that of in vivo brain tissue, allowing for future characterization of the
effects of likely important endogenous modifiers of R 1 in tissue, such as pO2, pH, and
protein content. We have also shown that the MFIR pulse sequence yields very similar
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results to the standard IR pulse sequence but that, in the presence 1H magnetization
transfer between water and cross-linked protein, pulse widths can have a substantial
effect upon relaxation characteristics and, thus, parameter estimates. Finally, we have
shown the utility of Bayesian-based model selection (and related parameter estimation)
for selecting amongst a cohort of competing signal models. As data become less
informative (e.g., sparser, lower SNR), simpler models (e.g., those with fewer parameters)
are preferred, in the Bayesian sense of being more probable, given the data and the prior
information.
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Chapter 3: Elucidating Challenges to 1H
Longitudinal Relaxation Quantification
of pO2 with a Tissue Mimic2
3.1 Introduction
Molecular oxygen (O2) is a vital component of energy production within the body, and
impaired delivery or consumption of oxygen is a recognized hallmark of metabolic
dysfunction and disease. Knowledge of tissue oxygen partial pressure (pO2) can aid in
diagnosis and treatment planning. For example, hypoxic tumors exhibit increased
resistance to chemotherapy[1] and radiation therapy[2], and increased angiogenesis[3].
Recent studies suggest that hypoxia in adipose tissue drives insulin resistance[4].
Impaired delivery of O2 is also a potential biomarker for placental dysfunction, inducing
long-term adverse outcomes for both mother and fetus[5, 6].
Robust methods for the non-invasive quantification of tissue pO2 are lacking. Optical
imaging techniques are sensitive to blood oxy- and deoxy-hemoglobin levels[7], which
can be modeled to yield, for example, the tissue metabolic rate of oxygen consumption[8]
and hemoglobin oxygen saturation[9-11]. Optical imaging has limited depth of
penetration, however, typically on the order of a few millimeters to a centimeter. Positron
Emission Tomography (PET) utilizes hypoxia-sensitive radiotracers to detect hypoxic

This chapter largely reflects a manuscript that has been submitted to Magnetic Resonance in Medicine
and is under revision, with minor additions relevant to the thesis.
(Kelsey Meinerz, Scott C Beeman, James D Quirk, G Larry Bretthorst, Joel R Garbow, and Joseph JH
Ackerman).
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cells[12-14]. However, PET spatial resolution is typically a millimeter or larger and
requires administration of radioactive isotopes.
Magnetic Resonance (MR) techniques are non-invasive, can probe the entire body, and
provide sub-millimeter spatial resolution. Blood-oxygen-level dependent (BOLD) MR
contrast results from alterations in the magnetic susceptibility of blood arising from
changes in the oxy-hemoglobin to deoxy-hemoglobin ratio[15]. An increase in the relative
amount of diamagnetic oxy-hemoglobin vs paramagnetic deoxy-hemoglobin decreases
the susceptibility difference between intra- and extra-vascular spaces. This increases the
magnetic field homogeneity over the affected tissue, leading to a decrease in the tissue
water 1H transverse relaxation rate constants (principally R 2* but also R2). In essence,
BOLD MRI leverages the magnetic state of hemoglobin to provide endogenous contrast
reflecting the oxygen content of blood. However, quantitative BOLD experiments are quite
challenging[16] and BOLD results are often expressed simply as signal change relative
to a baseline measurement.
A related technique, termed Tissue Oxygen Level Dependent (TOLD) MR, recognizes
that O2 is weakly paramagnetic and thus that dissolved oxygen affects the 1H longitudinal
relaxation rate constant (R1) of tissue water (see Ding, et al.[17], and references therein).
In principle, R1 is directly proportional to tissue pO2 via the relationship
R 1 =R 1,0 +r1 ∙pO2,

[1]

in which R1,0 is the longitudinal relaxation rate constant in the absence of oxygen and r 1
is the “relaxivity” of oxygen. TOLD protocols employ inhaled gas mixtures of varying
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oxygen content to change tissue pO2 while collecting R1-weighted images. Changes in
R1 are interpreted as resulting from changes in tissue pO2.
Knowledge of R1,0 and r1 would potentially allow for an R1-based method for true
quantification of pO2. However, as the solubility of O2 in water is limited (~1.1 mM or ~34
mg/L at 37 C and 1 atmosphere partial pressure of 100% O2[18]) and the O2 magnetic
relaxivity is weak (~14% that of Gd-DTPA[18, 19]), the effect of dissolved O2 on tissue
water relaxation is expected to be quite small[20, 21]. Indeed, we have previously
reported the oxygen r1 for in vivo mouse brain to be ~ 9 x 10 -4 mmHg-1s-1[22]. Thus,
substantial MR measurement and analysis challenges need to be addressed to account
for and/or mitigate other relaxation dependencies, e.g., blood flow[22], which compete
with the direct effect of oxygen on longitudinal relaxation in vivo.
Of specific relevance to this study, longitudinal relaxation of tissue water is better
approximated in practice by a biexponential model rather than a monoexponential
model[23-25]. This reflects, to first approximation, the presence of two apparent distinct
populations of 1H spins. The rapidly relaxing population, characterized by rate constant
R1,fast and fraction F, describes the minority population of water molecules that relax
quickly via magnetization transfer (MT) with the semi-solid macromolecular matrix. The
immobile protons associated with the macromolecular matrix have very large R 2 values
(very short T2; < 1 ms) such that direct detection via MR is unfeasible[26]. However,
through either direct chemical exchange, where the hydrogen nuclei themselves are
exchanged, or indirect dipole-dipole cross-relaxation, where the spin states between pairs
of nuclei are exchanged, magnetization is transferred and the water protons are aided in

51

their return to thermal equilibrium[27]. This MT effect is likely driven by direct chemical
exchange with solvent (water) accessible amides on the surface of proteins. The slowly
relaxing population, characterized by rate constant R 1,slow and fraction 1-F, describes the
majority population of water molecules. This slowly relaxing majority population is referred
to herein as “non-MT” although it is recognized that MT through mechanisms other than
rapid chemical exchange can affect relaxation at longer timescales[28]. The biexponential
function can be written as
Mz (t)= A+B[F* exp(-R 1,fast *t) +(1-F)* exp(-R 1,slow *t)].

[2]

in which A is a constant representing the signal intensity at equilibrium (t = ∞) and A + B
is the signal intensity at t = 0. Since the relaxivity of O 2 is small and MT dominates the
R1,fast spin population, we expect R1,fast will be relatively insensitive to oxygen
concentration. Indeed, data acquired on brain and muscle in mouse in vivo show that,
while R1,fast is insensitive to pO2 changes (Figure 3.1, B & E), R1,slow is linearly dependent
on pO2 (Figure 3.1, A & D). Therefore, the relationship from eq.[1] becomes
R 1,slow =R 1,0,slow +r1,slow *pO2 ,

[3]

where R1,0,slow is the background relaxation rate constant describing the slowly relaxing
component in the absence of dissolved tissue oxygen, and r 1,slow is the relaxivity of oxygen
pertaining to the slow component.
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Figure 3.1. Biexponential Modeling of Longitudinal Relaxation in Vivo vs Tissue
pO2 in the Mouse. A) R1,slow, B) R1,fast, and C) (1-F) as a function of pO2 in the thalamus
and D) R1,slow, E) R1,fast, and F) (1-F) as a function of pO2 in the gastrocnemius muscle.
Relaxation data were collected with the voxel placed directly beneath the OxyLite® probe
tip and tissue pO2 was modulated by administering varying breathing gas mixtures of O2
and N2. All animal experiments were approved by the Washington University Institutional
Animal Care and Use Committee. Each point is the result of a single PRESS-IR
experiment as described previously[24] at 4.7 T, selecting a (2 mm)3 voxel, with 64 TIs
ranging from 0.0075 s to 6 s, echo time (TE) of 14 ms, and a relaxation delay of 4 s (total
scan time 9 min 4 s). Relaxation data were fit to a biexponential model using Bayesian
probability theory-based methods[29]. Vertical error bars show ± a calculated standard
deviation, reflecting the uncertainty in the parameter estimation. Horizontal error bars
show ± a standard deviation of the directly measured pO2 values in the tissue over the
course of each PRESS-IR experiment. The relaxivity values for R 1,slow vs pO2 were
determined via the Errors in Variables package in the Bayesian analysis toolbox[30] and
are inlaid in A) and D).

In addition to blood flow, physiologic parameters such as temperature, pH, and protein
concentration also likely affect R1,slow, thereby confounding quantitative measurements of
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pO2. To understand the magnitude of these effects, cross-linked bovine serum albumin
(xBSA) was employed as an experimentally tractable phantom that mimics relaxation in
tissue[23, 24, 31]. Cross-linked bovine serum albumin exhibits a substantial MT effect
such that the longitudinal relaxation is better modeled as biexponential vs
monoexponential (Figure 3.2). As an in vitro tissue surrogate, its pH, temperature, and
protein content can be varied. Herein, we use xBSA phantoms to investigate and quantify
the relationship between R1 and pO2, and investigate the effects of potential physiologic
confounds on an R1-based pO2 measurement.

Figure 3.2. Longitudinal Relaxation in xBSA is Biexponential. A) Representative 128
TI relaxation time dataset (open diamonds) from the xBSA phantom, fit with the heavily
favored biexponential model (blue line) and the monoexponential model (red line). Early
time points are inlaid to show where the monoexponential model deviates most
significantly. B) Resulting residual amplitudes from fitting with both models. The
biexponential fit has a normalized root mean square (RMS) residual of 0.002, while the
monoexponential fit has a resulting RMS residual of 0.686.
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3.2 Methods
3.2.1 Phantom Preparation and Data Acquisition
xBSA samples were prepared by dissolving lyophilized bovine serum albumin (BSA)
powder (Sigma-Aldrich, St. Louis, MO, USA) in phosphate buffered saline (PBS, pH 7.4)
solution. The solution was prepared to be 30% (w/v) BSA for all experiments, except
those varying protein concentration. Samples were cross-linked using 2.5% (v/v) of a 50%
glutaraldehyde solution (Electron Microscopy Sciences, Hatfield, PA, USA) in a 35-mm
diameter polystyrene petri dish. Following the addition of glutaraldehyde, samples were
stirred by hand with a spatula for approximately one minute, covered in parafilm, and
placed into a sealed container in the refrigerator (~4C) for five days. Cylindrical pieces
of xBSA were then cored out and placed into a 5-mm, susceptibility-matched, NMR
microtube (Shigemi Inc, Allison Park, PA, USA) (Figure 3.3, A & B), sealed with parafilm,
and maintained at 37C for ~24 hours prior to data acquisition. Unless otherwise noted,
all MR experiments were performed with samples maintained at 37C.
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A

B

C
D

Figure 3.3. xBSA sample preparation. A) Full Shigemi tube with susceptibility matched
insert and B) zoomed-in image of Shigemi tube combination with cylindrical piece of xBSA
sample inside, for temperature, pH, and protein concentration modulation experiments.
C) Cylindrical xBSA sample with OxyLite® and temperature sensor embedded within it
for pO2 modulation experiment and D) xBSA sample and sensors placed in glass vial and
plastic bag prior to placement within the RF coil.

In experiments examining the dependence of xBSA relaxation on temperature, the
sample temperature was varied by initially equilibrating the samples at 40C overnight
using a heating block and acquiring data using an NMR probe maintained at 40C. This
overnight heating was dual purpose: 1) xBSA samples exhibited color and opacity
changes following crosslinking and heating and 2) was a matter of convenience. The color
and opacity changes occurred within a few hours of heating and it was unknown if the
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root of these changes would also affect the MR results, driving the decision to wait until
the samples had stabilized. Following data acquisition at 40C, the probe temperature
was lowered to 37C and samples were allowed to equilibrate prior to data collection at
that temperature. The probe temperature was then lowered to 34C, followed by another
equilibration period prior to data acquisition.
In experiments examining the dependence of xBSA relaxation on protein content, the
sample protein concentration was varied by initially dissolving lyophilized BSA powder
into PBS to create a solution that was 40% protein (w/v) and subsequently diluting this
sample to create solutions that were 30%, 20%, and 10% protein (w/v). Crosslinking and
subsequent sample preparation were as described above.
In experiments examining the dependence of xBSA relaxation on pH, the sample pH was
varied through the addition of either sodium hydroxide (NaOH) or hydrochloric acid (HCl)
to the 30% BSA solution before crosslinking. The pH of the solution prior to crosslinking
was measured using an Orion PerpHecT ROSS Comb Micro pH electrode probe (Thermo
Fischer Scientific Inc, Waltham, MA, USA). Crosslinking and subsequent sample
preparation were as described above. The pH of the crosslinked material was measured
by two different methods: (i) the electrode probe used in solution and (ii) NMR via

31P

measurements of the pH sensitive inorganic phosphate resonance[32]. The two methods
provided similar results; herein the reported values resulted from measurements via the
pH electrode.
In experiments examining the dependence of xBSA relaxation on pO 2, the sample pO2
was varied by blowing humidified O2 gas over a small xBSA cylindrical sample placed in
57

an open glass vial contained in a partially sealed plastic bag under positive pressure
(Figure 3.3, C & D). Sample pO2 was measured in real time via an implantable OxyLite®
(Oxford Optronix, Abingdon, Oxford, UK) O2-sensing optical microprobe at a rate of one
measurement per minute. Reported values are the averages of all measurements
performed over the course of each relaxation experiment and the error bars reflect the
calculated standard deviation of those values.
Agar gel samples were prepared by initially dissolving agar powder (Sigma-Aldrich, St.
Louis, MO, USA) in PBS at a concentration of 0.6% (w/v) agar. The agar solution was
heated in a boiling water bath, with occasional stirring, until the solution became
transparent. The solution was then removed from the bath, poured into polystyrene weigh
boats (Thermo Fischer Scientific Inc, Waltham, MA, USA) and allowed to cool overnight
at room temperature. Modulation of sample pO2 was varied by blowing humidified gas
mixtures over a small sample of this agar gel in an open glass vial contained in a partially
sealed plastic bag under positive pressure. The humidified gas was created by combining
N2 gas, O2 gas, and medical air (~20% O2) via a gas mixer (Matheson Tri-Gas, Irving, TX,
USA) and bubbling the subsequent gas mixture through a sealed flask of water. Sample
pO2 was monitored in real time as stated above.
1H

NMR relaxation experiments were performed on either (i) a 500-MHz (11.74 T) Agilent

(Agilent Technologies, Santa Clara, CA, USA) high-resolution (“analytical”) NMR
spectrometer in a standard 5-mm RF probe or (ii) a 11.74 T small-animal Agilent MRI
system using a 1.6 cm ID birdcage coil (Stark Contrast MRI Coils Research, Erlangen,
Germany). The former instrument was employed to quantify the relaxation dependence
upon temperature, pH, and protein concentration while the latter was employed to
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quantify the relaxation dependence upon pO2. Data acquisition on the analytical NMR
spectrometer employed a Modified Fast Inversion Recovery (MFIR) pulse sequence[33]
with acquisition parameters: 10,000 Hz bandwidth, 2,500 complex data points, water 1H
linewidth ~100 Hz, 128 exponentially spaced inversion delay times (TI) ranging from 5 ms
to 7.5 s. Total repetition time (TR = W + TI), where W is the relaxation delay, was 8.5 s.
Square radiofrequency (RF) pulses were employed for inversion and observation with a
typical 180 degree pulse ~1400 s (i.e., approximating the in vivo MR situation, which
maximizes the MT R1,fast component), and five discarded acquisitions were utilized to
achieve steady-state. A 1 ms crusher gradient was applied following the inversion pulse
to suppress any residual transverse magnetization arising from imperfect inversion.
Data acquisition on the MRI scanner also employed the MFIR pulse sequence in
combination with IR-PRESS single-voxel localization. Measurements on each sample
were acquired in triplicate with a (1.5 mm) 3 voxel that included the tip of the OxyLite®
sensor. MRS acquisition parameters were 4,000 Hz bandwidth, 2048 complex data
points, water 1H linewidth ~100 Hz, 64 exponentially spaced TIs ranging from 5 ms to 7.5
s. Total repetition time (TR = W + TI) was 8.5 s. Optimized RF pulses were employed for
inversion and observation[34], and five discarded acquisitions were utilized to achieve
steady-state. A 1 ms crusher gradient was applied following the inversion pulse to
suppress any residual transverse magnetization arising from imperfect inversion.
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3.2.2 Bayesian-Based Parameter Estimation
Relaxation parameters were estimated using Bayesian probability theory-based methods,
as described previously[24, 29, 30]. For these calculations, 400 parallel simulations were
performed within the Markov-chain Monte Carlo algorithm to sample the posterior
probabilities for the models and their associated parameters. A minimum of 400 annealing
steps brought the 400 simulations into a steady-state, at which point 30 samples were
drawn from each of the 400 simulations. Therefore, 12,000 parameter samples were
incorporated into the posterior probability density distributions for the models and their
parameters. The peak of the posterior probability distribution is the most probable
parameter estimate and the uncertainty for each parameter estimate is taken as the
standard deviation of the distribution.
In many cases, the results were calculated from a joint analysis of multiple replicate
datasets, where some model parameters are considered common for all included
datasets, while others are dataset specific. For the experiments that varied temperature,
pH, and BSA concentration, in which relaxation data was obtained in triplicate for two
samples from the same bulk material and relaxation data were collected in triplicate on
each, all reported model parameters (R1,slow, R1,fast, and (1-F)) were considered common
for the six replicate datasets while the initial and equilibrium magnetizations were
independent for each dataset. The optimal value for each of the common parameters was
that which best represented all six replicate datasets. For the experiments in which pO 2
was varied, each relaxation dataset was collected on a sample from a different bulk
material and optimal model parameters were determined for each dataset individually due
to potential variability between bulk materials. Thereafter, the resulting relaxation
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parameters vs pO2 datasets were fit jointly with a common slope (r1) but a unique intercept
(R1,0). The background relaxation rate constant (R 1,0) was allowed to vary between
datasets to reflect small potential variations in bulk material preparation. For comparison,
these individual datasets were also combined into a single dataset and modeled with both
a common slope (r1) and common intercept (R1,0), incorporating information about the
uncertainty in the relaxation parameters and the standard deviation of the pO 2
measurement at each point into the fit.

3.2.3 Data Truncation
To simulate the in vivo situation in which scan time is limited and accurate determination
of the rapidly relaxing component is impractical (and likely unnecessary, vide infra), the
xBSA relaxation data were truncated to include only the longer half of the TI values.
Therefore, the data remaining only include those associated with the slowly relaxing
component such that the shortest TI was approximately 200 ms.

3.3 Results
3.3.1 Temperature Dependence
Within the range 34 to 40 oC (physiologic normal ± 3 oC), both the fast and slow
longitudinal relaxation rate constants depend linearly on temperature (Figure 3.4, A & B).
In these figures, each data point represents the parameter estimation resulting from
Bayesian joint analysis of six replicate datasets. Across this range, R1,slow decreases with
increasing temperature with a slope of -0.011  0.003 C-1s-1 and a y-intercept of 0.9 
0.1 s-1 (R2 = 0.97), while R1,fast increases with a slope of 0.8  0.2 C-1s-1 and a y-intercept
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of 21  6 s-1 (R2 = 0.99). The fraction of the amplitude reflecting the slow component is
insensitive to temperature changes (Figure 3.4C).

Figure 3.4. Longitudinal Relaxation in xBSA is Temperature Dependent. A) R1,slow,
B) R1,fast, and C) (1-F) as a function of temperature variations about physiologic normal.
Each point in the plot is the result of Bayesian joint analysis of six replicate datasets, with
vertical error bars reflecting the uncertainty in the joint parameter estimation, and
horizontal error bars reflecting uncertainly in the temperature maintenance of the
spectrometer. R1,slow and R1,fast both depend linearly on temperature, (1-F) is unchanged
with temperature. The trendline for R1,slow is described by the equation y = (-0.011  0.003
C-1s-1)x + (0.9  0.1 s-1) with an R2 coefficient of 0.97, the trendline for R1,fast is y = (0.8 
0.2 C-1s-1)x + (21  6 s-1) with an R2 coefficient of 0.99, and the trendline for (1-F) is y =
(0.001  0.001 C-1)x + (0.84  0.05) with an R2 coefficient of 0.15.

3.3.2 Protein Content Dependence
For the range of protein concentrations studied, both the fast and slow relaxation
components and the fractional amplitude of those components depend linearly on BSA
concentration, i.e., protein density (Figure 3.5). In this figure, each point represents the
parameter estimation resulting from Bayesian joint analysis of six replicate datasets. As
the protein concentration increases, R1,slow increases with a slope of 0.010  0.005 (w/v)1s-1

and a y-intercept of 0.2  0.1 s-1 (R2 = 0.82) and R1,fast increases with a slope of 0.4 
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0.1 (w/v)-1s-1 and a y-intercept of 41  4 s-1 (R2 = 0.89). The fraction of the total amplitude
describing the slow component also shows a linear relationship with BSA concentration,
decreasing with a slope of -0.0034  0.0009 (w/v)-1 and a y-intercept of 0.98  0.02 (R2 =
0.95).

Figure 3.5. Longitudinal Relaxation in xBSA is Protein Concentration Dependent.
A) R1,slow, B) R1,fast, and C) (1-F) as a function of BSA concentration. Each point in the
plot results from Bayesian joint analysis of six replicate datasets, with vertical error bars
reflecting the uncertainty in the parameter estimation and horizontal error bars reflecting
the estimated uncertainty in concentration determination. R 1,slow, R1,fast, and (1-F) are
linearly related to macromolecule concentration. The trendline for R1,slow is described by
the equation y = (0.010  0.005 (%w/v)-1s-1)x + (0.2  0.1 s-1) with an R2 coefficient of
0.82, the trendline for R1,fast is y = (0.4  0.1 (%w/v)-1s-1)x + (41  4 s-1) with an R2
coefficient of 0.89, and the trendline for (1-F) is y = (-0.0034  0.0009 (%w/v)-1)x + (0.98
 0.02) with an R2 coefficient of 0.95.

3.3.3 pH Dependence
Over the range of pH 6.0 to 7.0, both the fast and slow relaxation rate constants are
linearly related to pH (Figure 3.6). In this figure, each point represents the parameter
estimation resulting from Bayesian joint analysis of six replicate datasets. As pH
increases, R1,slow decreases with a slope of -0.08  0.01 s-1 and a y-intercept of 1.18 
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0.09 s-1 (R2 = 0.97), while R1,fast decreases with a slope of -11  4 s-1 and a y-intercept of
130  30 s-1 (R2 = 0.83). The fractional amplitude of the slow component shows a slight
increase with pH with a slope of 0.03  0.01 and a y-intercept of 0.68  0.07 (R2 = 0.85).
Note that at the lowest pH value, relaxation does not fit the trend observed over the pH
range of 6.0 – 7.0. At low pH, serum albumin is known to undergo reversible
conformational changes that can lead to differences in the final crosslinked product [35].

Figure 3.6. Longitudinal Relaxation in xBSA is pH Dependent. A) R1,slow, B) R1,fast,
and C) (1-F) as a function of pH. Each point in the plot is the result of Bayesian joint
analysis of six replicate datasets, with vertical error bars reflecting the uncertainty in the
joint parameter estimation and horizontal error bars reflecting the calculated standard
deviation of the measured pH. R1,slow and R1,fast are sensitive to changes in pH. The
trendline for R1,slow is described by the equation y = (-0.08  0.01 s-1)x + (1.18  0.09 s-1)
with an R2 coefficient of 0.97, the trendline for R1,fast is y = (-11  4 s-1)x + (130  30 s-1)
with an R2 coefficient of 0.83, and the trendline for (1-F) is y = (0.03  0.01)x + (0.68 
0.07) with an R2 coefficient of 0.85. Note that at the lowest pH value, relaxation does not
reflect the trend observed over the pH range of 6.0 – 7.0 and was therefore excluded from
the linear fit. At low pH, serum albumin undergoes reversible conformational changes that
can lead to differences in the final product following crosslinking[35].
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3.3.4 pO2 Dependence
Over the range of 20 to 80 mmHg, we observed a linear relationship between pO 2 and
R1,slow in xBSA tissue mimics (Figure 3.7A) and the relative insensitivity of R1,fast and the
fractional amplitude to changes in pO2 changes (Figure 3.7, B & C), as predicted. When
the four experiments were analyzed jointly with a common-valued slope but unique yintercepts, r1,slow was found to be 0.00212  0.00005 mmHg-1s-1.

Figure 3.7. Longitudinal Relaxation in xBSA is pO2 Dependent. A) R1,slow, B) R1,fast,
and C) (1-F) as a function of pO2 in multiple xBSA samples. Each color represents a
separate sample preparation, the solid lines for each of the four colors represent the fit
from a joint analysis in which the slope had a common value while the y-intercept was
unique for each dataset. The dotted gray line represents the fit that results if all the data
from the four experiments are combined into a single dataset and fit with a linear model.
In A), the joint and combined relaxivities for the slow component are 2.12 x 10-3  5 x 105 mmHg-1s-1 and 1.23 x 10-3  8 x 10-5 mmHg-1s-1, respectively. In B), the joint and
combined relaxivities for the fast component are 0.07  0.01 mmHg-1s-1 and 0.03  0.01
mmHg-1s-1, respectively. In C), the joint and combined slopes for the fractional amplitude
are -3.1 x 10-4  3 x 10-5 mmHg-1 and -2.2 x 10-4  2 x 10-5 mmHg-1, respectively.
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Table 3.1. Effects of temperature, pH, protein concentration, and pO2 on relaxivities
and volume fraction of xBSA
Parameter

r1 Units

r1,slow

r1,fast

(1-F) slope

Truncated r1
(Monoexponential)

Temperature

°C-1s-1

-0.011
(0.003)a

0.8 (0.2)a

0.001 (0.001)a
[°C-1]

-0.010 (0.003)a

pH [6.0-7.0]

s-1

-0.08
(0.01)a

-11 (4)a

0.03 (0.01)a

-0.08 (0.02)a

BSA
Concentration

(%w/v) -1s-1

0.010
(0.005)a

0.4 (0.1)a

-3.4E-3 (9E4)a [(%w/v) -1]

0.010 (0.005)a

pO2

mmHg-1s-1

2.12E-3
(5E-5)b

0.07 (0.01)b

-3.1E-4 (3E5)b [mmHg-1]

2.05E-3 (6E-5)b

Values reported as mean (calculated parameter uncertainty)
a Resulting from Given Polynomial Order package in the Bayesian analysis toolbox.
b Resulting from joint linear model from the Enter Ascii Model package in the Bayesian
analysis toolbox in which slope is common valued while y-intercepts are allowed to vary
across datasets.
Over the range of 0 to 150 mmHg, the linear relationship between pO 2 and R1 in agar is
additionally confirmed (Figure 3.8) with considerably higher inter-sample precision
compared to xBSA samples. However, this agar sample does not exhibit the full
characteristics of a tissue mimic as it does not show a fast relaxing MT component (i.e.,
its longitudinal relaxation is monoexponential). When the three experiments were jointly
analyzed with a common-valued slope but unique y-intercepts, r1 in agar was found to be
0.00019  0.00006 mmHg-1s-1.
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Figure 3.8. Longitudinal Relaxation in Agar Gel is pO2 Dependent. R1 as a function
of pO2 in multiple 0.6% (w/v) agar samples with each color denoting a separate sample
preparation. The solid lines for each of the three colors represent the resulting fit from a
joint analysis in which the slope had a common value, while the y-intercept was unique
for each of the three datasets. The dotted gray line represents the fit that results if all the
data from the three experiments are combined into a single dataset and fit with a linear
model. The joint and combined relaxivities for the rate constant are 0.00019  0.00006
mmHg-1s-1 and 0.00018  0.00002 mmHg-1s-1, respectively.

3.4 Discussion
3.4.1 The Two-Component Relaxation (Biexponential) Model
Modeling the 1H longitudinal relaxation of water in xBSA as reflecting two, idealized,
monoexponentially-relaxing, water populations (MT and non-MT) is, of course, an
approximation. There is exchange between the two populations, although this exchange
is sufficiently slow such that the two-component relaxation character is clearly evident
and the two orders of magnitude difference between observed rate constants implies that
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the system lies close to the slow exchange limit. Therefore, the observed rate constants
and amplitudes should approximate the true population amplitudes and rate constants.
Additionally, exchangeable 1H in proteins exhibit a range of exchange rate constants
(inverse of pre-exchange lifetimes)[36, 37], thus, R1,fast is an “apparent” or “effective” rate
constant. While the fast relaxing water 1H MT population is likely dominated by solvent
(water) accessible primary amide groups, e.g., amide moieties on the peptide surface, it
is unrealistic to assume a single pre-exchange lifetime for all “fast” exchange sites. Similar
considerations apply to R1,slow; it is an apparent or effective rate constant, one that best
captures the slow relaxation character of the non-MT pool.

3.4.2 Temperature Dependence
While 37.0 C  0.5 C is considered the normal human body temperature, interpersonal
and intrapersonal temperature variations are expected due to a number of factors,
including a person’s circadian rhythm[38]. xBSA phantom measurements described
herein found a linear dependence of R1,fast (increasing) and R1,slow (decreasing) over a 3440 C temperature range.
While the effect is modest, it is consistent with a temperature-driven (i) increase in the
rate of 1H magnetization exchange (magnetization transfer) between the semi-solid-like
macromolecular matrix and highly mobile tissue water and (ii) an increase in the
correlation time of the highly mobile tissue water. These data imply that modest changes
in tissue temperature will affect measured values of R 1,slow, thereby confounding
quantification of tissue pO2. Therefore, the accuracy of an R1,slow-based method for
quantifying pO2 in vivo will depend on knowledge of tissue temperature.
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In some cases, the use of minimally invasive, MR-compatible, implantable probes, i.e.,
fiber optic sensors, will allow measurement of tissue temperature. However, some regions
of the body, i.e., brain tissue, are inaccessible via such methods. Magnetic Resonance
Spectroscopy (MRS) techniques can in some cases be used to determine tissue
temperature via the temperature-sensitive 1H chemical shift of water relative to a
reference resonance. For example, in the brain, the chemical shift of water relative to
NAA can provide precise measurements of tissue temperature[39].

3.4.3 Protein Content Dependence
As expected from the simple two-population model (MT and non-MT), both the measured
R1,fast and R1,slow increase (linearly) with BSA concentration. This is consistent with (i) an
increase in sites for MT as the concentration (density) of the semi-solid-like
macromolecular matrix increases with an increase in protein concentration and (ii) the
presence of slow exchange between the two water populations. Note that F, the
population fraction of the fast relaxing (MT pool) also increases (1-F decreases) with
protein concentration, consistent with the two-population model.
Protein concentration varies across tissue types in vivo[40] and will need to be considered
in development of R1,slow-based pO2 quantification. Fortunately, protein concentration in
various tissues has been studied, with results reported in the literature[41, 42]. For
example, it has been reported that muscle cells are approximately 23% protein by weight,
and actively growing cells approximately 17-26% protein by weight[40].

3.4.4 pH Dependence
1H

exchange between amide groups in proteins and solvent (water) is acid, base, and ion
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catalyzed. Principal sites for the chemical-exchange-driven MT that results in the fast
relaxing component in the xBSA phantom are solvent accessible primary amides. Given
their weak acidity, pKa > 15, a pH change from 6 to 7 is expected to produce a negligible
shift in amide protonation state. However, the number of fast exchanging 1H sites has
been shown to increase as the pH increases from 5 to 8. This has been proposed[36] to
be due to subtle changes in the protein’s equilibrium conformational ensemble, resulting
in an increase in the population of solvent accessible 1H exchange sites. Nevertheless,
irrespective of the underlying mechanism that changes some of the slow 1H exchange
sites into fast 1H exchange sites, it is likely that a substantial fraction of these new fast
exchange sites are only partially solvent accessible, compared to fast exchange sites on
the protein surface. Thus, these new 1H exchange sites are characterized by “fast” rate
constants that are somewhat slower than those of the fully solvent accessible 1H
exchange sites. The addition of these “slower” fast exchange sites with increasing pH
could cause a decrease in R1,fast and, due to exchange between the two relaxation
populations, MT and non-MT, a decrease in R1,slow. Amide exchange has been reported
to decrease with decreases in pH[43, 44]. Therefore, as pH increases - driving faster
exchange - the observed population fraction of the slow component (1-F) is increasingly
weighted by the dominant slow component.
Tissue pH is known to vary across tissue types, with some evidence suggesting variability
even within an extended region of similar tissue, i.e., variation across regions of the
brain[45]. Additionally, studies have shown significant changes in tissue pH following
incision[46], development of arthritis[47], and in tumor vs healthy tissue[48]. Precise
characterization of pH in vivo is challenging, as most implantable probes are invasive and
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not MR-compatible. Alternatively, a variety of MR-detectable molecules, both
endogenous and exogenous, have been employed to determine pH in vivo[49].
Endogenous phosphorus metabolites[32, 50] and histidine[51] have pH-dependent
and

1H

chemical

shifts,

respectively.

Administration

of

exogenous

31P

3-

aminopropylphosphonate (3-APP)[52] or (±) 2-imidazole-1-yl-3-ethoxycarbonyl propionic
acid (IEPA)[53], also yield detectable agents with pH-dependent

31P

and 1H chemical

shifts, respectively. Recently, chemical exchange saturation transfer has been exploited
to yield measures of tissue pH[49]. The use of MR to accurately determine tissue pH
remains an area of active interest and will be important in quantifying pO 2 via tissue water
1H

relaxation.

3.4.5 pO2 Dependence
One of the motivating aims underlying this phantom study was to elucidate the factors
that would affect the use of 1H longitudinal relaxation of tissue water to derive tissue pO2.
Thus, the effects of temperature, protein concentration, and pH were examined. However,
central to the use of 1H longitudinal relaxation of tissue water to derive tissue pO2 is
defining the 1H water relaxivity of O2 in a tissue-like environment. Toward this end, 1H
water relaxation in xBSA was measured under conditions of variable pO2. The r1,slow
determined for xBSA at 11.7 T is ~ 2 to 3 fold larger than those determined in our
preliminary in vivo results at 4.7 T, possibly a manifestation of magnetic-field-strengthdependent relaxation.
Normal tissue pO2, otherwise referred to as physioxia[54], has been characterized using
invasive probes in various tissues, including 33.8  2.6 mmHg in brain tissue, 57.6  2.3
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mmHg in intestinal tissue, 40.6  5.4 mmHg in the liver, and 29.2  1.8 mmHg in muscle
tissue[55]. The range of pO2 values investigated in the xBSA phantom study greatly
exceeded the range of pO2 values characteristic of in vivo tissue. This increased dynamic
range was designed to provide improved characterization of the relationship between pO 2
and R1,slow. The reduced dynamic range in vivo is an additional challenge for tissue pO 2
studies, further emphasizing the importance of a more precise signal model that accounts
for the additional physiologic confounds explored in this work.
The difficulty in reproducibly determining the relationship between R 1,slow and pO2 in xBSA
phantoms, which we speculate was due to internal variations in the individual sample
preparations, led us to verify our methodology in additional media, including agar gel
(Figure 3.8). A gel made with 0.6% (w/v) agar solution was chosen, as this concentration
has been shown to be a good in vitro surrogate for brain tissue[56]. While the agar gel
does not mimic tissue’s biexponential longitudinal relaxation characteristic[57], the
reproducibility of the linear relationship between R 1 and pO2 from our measurements is
greatly improved compared with the variations seen in the xBSA samples. The r 1 of
oxygen in the agar gel is very close to reported r 1 values in aqueous liquids[20, 21, 58]
as the concentration of agar in this gel is only 0.6% w/v and the MT effect is absent. These
results confirmed that our experimental design was capable of reproducibly determining
the linear relationship between R1 and pO2.
A number of difficulties or surprising anomalies arose from using xBSA. For instance, a
change in color and opacity was noticed as the sample aged over the course of a few
days, suggesting some internal changes occurring during that time. This led to the
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decision to age all xBSA samples for 5 days prior to experiments to improve sample
consistency. Another surprising result was that the initial pO2 measurement for xBSA was
consistently on the order of a few mmHg or less, regardless of the time following chemical
crosslinking. Additionally, the apparent diffusivity of O2 through xBSA was significantly
slower than that of the agar gel, taking tens of hours to increase by 60 mmHg in xBSA
with pure O2 gas as opposed to tens of minutes to increase by more than 100 mmHg in
the agar gel with medical air (~20% O2). Other works have focused on developing tissue
mimics which have similar T1 and T2 properties as various tissues[59, 60]. However, these
studies only employed a monoexponential model when determining relaxation
parameters and therefore do not entirely capture the underlying biophysics. Lamellar
liquid crystals[61] have been shown to display biexponential relaxation, however the
composition of this sample deviates from that of in vivo tissue. Development of a phantom
that mimics in vivo tissue both in composition and in relaxation characteristics remains an
open field of study.
In moving from phantom to in vivo measurements of pO2, the effects of blood flow provide
an additional confounding factor that must be mitigated or modeled. For example, in 2D
slice-selective protocols the blood-flow-driven inflow of ~ Boltzmann-equilibrium polarized
1H

spins from outside the slice produces an increase in the tissue’s apparent R 1 (reduced

apparent T1) within the selected slice. Employing a non-slice-selective inversion pulse in
inversion-recovery-type relaxation protocols substantially mitigates this effect. Further,
employing weak diffusion sensitizing gradients prior to readout markedly reduces any
transverse magnetization coherence within the vasculature, thus mitigating confounding
signals from blood.
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Additionally, the relaxation experiments in xBSA phantoms were all performed at 11.74 T
and while preclinical in vivo experiments can be performed at this field strength, clinical
scanners currently operate at lower fields. Clinical translation of the phantom results, as
well as preclinical measurements at other field strengths, will require a careful
characterization of field-strength-dependent effects for incorporation into a combined
signal model. Further, in vivo experiments place constraints upon the time allotted for the
R1 measurement. R1,slow is more readily/accurately quantified than R 1,fast and, therefore,
requires significantly fewer inversion recovery delay times to determine precisely. A faster
acquisition could then be utilized that contains a smaller array of TI values necessary to
characterize the slowly relaxing component. Table 3.1, showing the results of using only
the latter/longer half of the set of TI values collected in the analysis fit with a
monoexponential, demonstrates that these truncated relaxivity results are essentially
identical to the slow component relaxivities for each varied parameter.
Given the challenges in utilizing 1H longitudinal relaxation to quantify tissue pO2 in vivo,
additional applications should also be considered. Tissue engineering and in vitro
organogenesis show promise as potential solutions to the worldwide shortage of donor
tissues for transplantation[62, 63]. However, these techniques are not yet widely available
in the clinic because methods for providing proper oxygen supply to the tissue scaffolds
are still being investigated. Our R 1,slow-based technique for non-invasively monitoring
tissue pO2 could be used to aid in the development of best practices for oxygen delivery
to facilitate proper tissue growth and development.
In conclusion, we have investigated physiologic confounds to an R 1,slow-based method for
pO2 quantification in tissue using xBSA phantoms. As observed with in vivo tissue, R 1
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relaxation in these phantoms is well modeled as biexponential, with the slower
component, R1,slow, demonstrating a linear dependence on sample pO2. Experiments in
which temperature, BSA concentration, and pH were varied independently demonstrate
clearly that R1 relaxation depends upon each of these factors. Applications of R 1,slowbased methods for pO2 quantification must properly account for their effects.
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Chapter 4: MRI-Derived Biomarkers
Assess Placental Function &
Development in Mouse Models of
Placental Insufficiency3
4.1 Introduction
Placental dysfunction can lead to life threatening situations for both mother[1, 2] and
fetus[3-6]. Pre-eclampsia (PE), estimated to affect 2-8% of pregnancies worldwide, is the
leading cause of maternal and perinatal morbidity and mortality[7, 8], and involves altered
vascular development within the placenta[9]. Intrauterine growth restriction (IUGR),
characterized by a fetus that is small for gestational age, is estimated to affect 3-7% of
pregnancies worldwide[10], and can lead to an increased risk of perinatal mortality and
morbidity[11]. There are many potential causes for IUGR, including insufficient delivery
of nutrients or oxygen, infection with TORCH pathogens[12] which are able to cross the
placenta, genetic predisposition, and various maternal disorders or stress factors[13].
Often, the treatment protocol for mothers diagnosed with severe PE or IUGR is early
delivery, though determining optimal timing for delivery to ensure the best outcome for
both fetus and mother remains a challenge[7, 11]. Establishing quantitative biomarkers
of placental development and function could provide a means for determining when fetal
development is no longer being properly supported, a trigger for early delivery. Magnetic

This chapter largely reflects a manuscript that is in preparation, with minor additions relevant to the
thesis.
(Kelsey Meinerz, James D Quirk, and Joel R Garbow).
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resonance imaging (MRI) is a non-invasive modality for generating high-resolution, in vivo
images having outstanding soft-tissue contrast that are sensitive to tissue microstructure
and physiology. MRI is, therefore, an excellent tool for probing placental function and
development during gestation.
While placental shapes and structural designs vary wildly across mammals[14], humans,
many primates, and rodents have discoid hemochorial placentas with a distinct layer
structure [15, 16]. With respect to the fetus, the most proximal layer, the labyrinth zone in
mice and the ‘fetal placenta’ in humans, is characterized by both maternal and fetal blood
supplies and is the main site of exchange between these systems[15]. The middle layer,
the junctional zone in mice and the basal plate in humans, contains only maternal blood
that flows in and out of the most proximal layer. The most distal layer is significantly
different between mice and humans[15]. As a consequence, we focused on the two
murine layers that are analogous to the human placenta, the labyrinth and junctional
zones.
The strains of mice we studied typically deliver at embryonic day 19.5 (E19.5) [17] and in
contrast to humans, the murine uterus is composed of two horns, each associated with
an ovary[18], which is designed to accommodate large litters of fetoplacental units. Blood
flow within the uterine loop is bidirectional[18] and while having multiple fetoplacental
units per dam increases imaging efficiency, movement of the uterus within the abdominal
cavity over time makes it challenging to uniquely track individual fetoplacental units
across gestation. Techniques to non-invasively determine the order of fetoplacental units
within a uterine horn via MRI exist[19], but are challenging and would have added
significant time to an already lengthy imaging protocol.
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Numerous murine models of abnormal pregnancy have been established, including
models of PE[20, 21] and IUGR[22-24]. Interleukin 10 knock-out (IL-10 KO) mice display
increased inflammatory reactions[25] and when pregnant and treated with polyinosinicpolycytidylic acid (Poly(I:C)) develop symptoms characteristic of PE[20], including
hypertension and proteinuria. Herein we employed the “crowded uterine horn” model of
IUGR[22] wherein super ovulation is induced via removal of a single ovary prior to mating.
As each horn has its own cervix, the eggs released from one ovary are confined to that
horn, resulting in the entire litter being located within a single horn. Blood enters the
uterine horn from both the ovarian and uterine arteries and fetoplacental units located
within the middle of the horn receive diminished blood flow and reduced nutrient and
oxygen content, resulting in fetuses characterized by fetal growth restriction (FGR) [22].
For the purposes of this study, fetoplacental units from the middle third of the total litter in
each dam were deemed IUGR.
MRI can non-invasively probe the entirety of the abdomen with sub-millimeter resolution,
allowing placental volume measurements at multiple time points across gestation in the
same animals. Additionally, the MRI longitudinal relaxation rate constant (R1) and the
effective transverse relaxation rate constant (R2*) can be measured and used to infer
information about the amounts of oxygen within the tissue and vasculature, respectively.
As molecular oxygen (O2) is weakly paramagnetic, R1 is, in principle, directly proportional
to local tissue pO2

[26-28] and has been used as a measure of placental

oxygenation/hypoxia[29, 30]. R2* has been shown to be linearly proportional to the
concentration of deoxyhemoglobin within the vasculature[31, 32]. Measuring these rate
constants while the mother is breathing medical air (20% O2) and during a gas challenge
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with 100% O2 probes the level of placental function and its response to environmental
changes.
The purpose of this study is to use MRI to non-invasively probe placental development
and investigate biomarkers of placental function in late gestation for established mouse
models of common placental dysfunctions.

4.2 Methods
4.2.1 Mouse Models of Placental Insufficiency
All animal experiments were approved by the Washington University Institutional Animal
Care and Use Committee. An overview of the protocol for these experiments is shown in
Fig. 4.1 A. Pregnant, healthy C57BL/6 dams were received E11.5 in gestation from
Charles River Laboratories (Wilmington, MA, USA). Non-pregnant C57BL/6 females and
males were ordered from Charles River Laboratories and bred to generate the IUGR
cohort. Prior to breeding, a left hemi-ovariectomy was performed on the female mice,
which were allowed a minimum of two weeks to recover before breeding. A colony of IL10 KO mice was established with mice purchased from Jackson Laboratory (Bar Harbor,
ME, USA; stock #002251)[25]. All in-house breeding was managed by the Mouse
Genetics Core facility at Washington University in St Louis.
To intensify PE-like symptoms in pregnant IL-10 KO dams, each received a 2.5 mg/kg
intraperitoneal (IP) injection of 1 mg/mL Poly(I:C) high molecular weight solution
(InvivoGen US, San Diego, CA, USA) on days E12.5, E14.5, and E16.5. IP injections

84

were administered carefully, restricting the needle’s depth of penetration to just below the
peritoneum, to avoid injury to fetoplacental units in the abdomen.

Figure 4.1. Overview of the experimental and imaging protocols. A) Experimental
protocol: Poly(I:C) IP injections were administered only to IL-10 knockout mice (PE
model). B) Imaging protocol: The minimum equilibration period after switching breathing
gases was 2 minutes. Identical regions of T2-weighted anatomic images in the same
E14.5 IUGR dam breathing C) 100% O2 and D) medical air (20% O2). Three placentas
are indicated with yellow arrows. One complete placenta is outlined in green, while a
second placenta, segmented into labyrinth (yellow outline) and junctional (blue outline)
zones by our automated algorithm is shown in C). Image contrast within the placenta
between the labyrinth and junctional zones is lost when breathing medical air.

4.2.2 MRI Protocol and Analysis
An overview of the imaging protocol is shown in Fig. 4.1 B. MRI experiments were
performed on a 11.74-T small-animal MRI system (Agilent Technologies, Santa Clara,
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CA, USA) using a 5-cm ID birdcage coil (Extend MR LLC, San Francisco, CA, USA) at
gestational days E14.5 and E17.5. In this study, 11 Healthy dams, 14 IUGR dams, and
18 PE dams were imaged. Mice were anesthetized with isoflurane (3% for induction, 12% for maintenance) mixed with oxygen (1 L/min), delivered through a nose cone. Once
anesthetized, animals were placed in the supine position on a custom-built imaging cradle
and taped across the abdomen to restrict respiratory motion. Respiration rate and body
temperature were monitored using an MR-compatible monitoring and gating system (SA
Instruments, Inc., Stony Brook, NY, USA). Body temperature was maintained at 37C via
circulation of warm air and the respiration rate was maintained at ~50 breaths per minute
through modulation of anesthesia. Halfway through the MRI study, the anesthesia
delivery gas was switched to medical air (20% O2) and the mice were allowed to
equilibrate for a minimum of two minutes prior to additional imaging.
The volumes of all placentas (5-10/mouse) were calculated by manual segmentation of
respiratory-gated, T2-weighted, multi-slice spin-echo images (SEMS). Each placenta was
automatically divided into labyrinth and junctional zones based on the relative intensities
of each voxel using Otsu’s method[33]. The SEMS parameters were: time to repetition
(TR) = 1500 ms; echo time (TE) = 30 ms; field of view, 4.8 x 6.4 cm 2; matrix, 96 x 256,
zero-filled to 192 x 256 to yield in-plane resolution of 0.25 mm; 0.5 mm slice thickness; 1
average; scan time ~ 15 minutes. High resolution images were collected with a data
matrix of 512 x 192, zero-filled to 512 x 384 to yield in-plane resolution of 0.125 mm. For
R1 mapping, a 3D gradient-echo variable flip angle (VFA) imaging sequence with TR/TE
= 50/2.1 ms, utilizing five flip angles (5, 10, 15, 30, and 50 degrees) was acquired[34].
The flip angles used were optimized for characterizing the following signal model[34]
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M0 sin(𝜃) (1 − 𝑒 −𝑅1∗𝑇𝑅 )
𝑆𝐼𝑉𝐹𝐴 (𝜃) =
1 − cos(𝜃) 𝑒 −𝑅1∗𝑇𝑅
in which SIVFA is the VFA signal as a function of flip angle, , and M0 incorporates the
proton density. Using R1 values from preliminary experiments and normalizing M0 to one,
the expected range of SIVFA curves is shown in Fig 4.2. Five flip angles were then chosen
to accurately characterize the SIVFA curve and stratify curves for differing R1 values within
the expected range.

Figure 4.2. SIVFA curves as a function of  (in radians) for the expected range of R1 values:
R1 = 0.25 s-1 [solid blue]; R1 = 0.3 s-1 [dashed orange]; and R1 = 0.2 s-1 [dashed yellow].
Each SIVFA curve is overlaid with the chosen flip angles [pink stars].

The flip angle that is most sensitive to R 1 differences over the expected range was
determined by calculating the derivative of the difference between the SIVFA curves for R1
= 0.3 s-1 and R1 = 0.2 s-1 and solving for , which was approximately 0.28 radians or 16.
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This calculated flip angle represents the optimum value for this expected R 1 range for a
single flip angle. As we were using five flip angles, we selected a range of flip angles
about the optimum flip angle, as shown in Fig. 4.3.

Figure 4.3. SIVFA curves as a function of R1 showing the optimal flip angle ( = 16) [solid
purple] and the middle three flip angles ( = 10 [dashed blue],  = 15 [dashed orange],
and  = 30 [dashed yellow]) from the chosen range of 5 flip angles for the expected range
of R1 = 0.2 s-1 to 0.3 s-1.

For R2* mapping, a 3D multi-echo, gradient-echo imaging sequence was acquired with
TR = 50 ms, flip angle = 15 degrees, six echoes starting at 2.1 ms, and an echo spacing
of 4 ms. The echo times used were optimized for the following signal model:
∗

𝑆𝐼𝑇𝐸 (𝑡) = 𝑆𝐼0 𝑒 −𝑡∗𝑅2
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where SITE is the signal intensity as a function of time, t, and SI0 is the baseline signal
intensity. Using R2* values from preliminary experiments and normalizing SI0 to one, the
expected range of SITE curves as a function of time are shown in figure 4.4 A. The echo
time that is most sensitive to R2* differences over the expected range was determined by
calculating the derivative of the difference between the SI TE curves when R2* = 100 s-1
and R2* = 40 s-1 and solving for t to find the optimum TE, which was approximately 15.3
ms. The minimum TE of 2.1 ms was dictated by the scanner hardware and the echo
spacing was chosen to be 4 ms such that the final array of 6 echoes was distributed about
the optimum TE, as shown in figure 4.4 B.

Figure 4.4. A) SITE curves as a function of t in seconds for the expected range of R 2*
values: R2* = 40 s-1 [dashed blue]; R2* = 70 s-1 [solid orange]; and R2* = 100 s-1 [dashed
yellow]. B) The SITE curves as a function of R2* for the optimum TE = 15.3 ms [solid blue
line] and the array of chosen TEs for the acquisition [dashed lines].

R1 and R2* maps were acquired both while the dams were freely breathing medical air
(20% O2) and 100% O2 to modulate tissue and vasculature oxygenation. Optimal
relaxation rate constants were determined via Bayesian probability theory based
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software[35] on a voxel-wise basis. Herein, the data points reflect the average across all
voxels within a segmented region and the reported values represent the median of each
distribution of points.
Placentas that were not fully covered by the anatomical scans were excluded from the
volume results, but were included for R1 and R2* mapping. The numbers of full placentas
at E14.5 were 95 (PE), 66 (healthy), and 21 (IUGR), while at E17.5, the numbers were
78 (PE), 63 (healthy), and 31 (IUGR), respectively. The combined numbers of full and
partial placentas at E14.5 were 101 (PE), 82 (healthy), and 44 (IUGR), while at E17.5,
the numbers were 88 (PE), 62 (healthy), and 44 (IUGR). Midway into the study, we
determined that the T2 contrast between the labyrinth and junctional zones was improved
in anatomic images acquired while the mother was breathing 100% O2 (Figs. 4.1 C and
4.1 D). Overall volume determinations were unaffected by breathing gas. The zonespecific analysis was only applied to images collected under 100% O 2; the numbers of
such placentas at E14.5 were 18 (PE), 14 (healthy), and 44 (IUGR), while at E17.5, these
numbers were 15 (PE), 14 (healthy), and 41(IUGR).
Following imaging on E17.5, IL-10 KO and healthy control mice were euthanized via
cervical dislocation and an autopsy was performed to determine the size of the litter, note
the number and location of unhealthy or resorbing fetuses, and weigh each placenta. For
IUGR dams, euthanasia was performed with an IP injection of pentobarbital without
disturbing the dam from the supine position in the imaging cradle. The autopsy was
performed carefully and video-recorded so that the order of fetoplacental units from the
ovary to the cervix could be determined and later matched to the anatomic images.
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Manual segmentation was performed on the SEMS images and the resulting regions of
interests were translated to the R1 and R2* maps using VOXA (VOXel based image
Analysis toolset) custom image processing tools implemented in MATLAB (Mathworks,
Natick, MA, USA) and co-developed by Pfizer, Inc. and the Mallinckrodt Institute of
Radiology. Statistical analysis was performed using Origin (OriginLab Corporation,
Northhampton, MA, USA) and the free and open source Jamovi Project software (The
Jamovi Project, www.jamovi.org) using ANOVA and post hoc Tukey tests, in which p <
0.05 was regarded as statistically significant.
Herein, quantitative results are reported in the form of box and whisker plots to visualize
the summary statistics, overlaid with the individual data points. The mean of each
distribution is represented by an open square and the median is represented by the
midline of the box. The top and bottom edges of the box represent the 75 th and 25th
percentiles, respectively, and the range which they cover is referred to as the interquartile
range. The top and bottom whiskers represent the 95 th and 5th percentiles, respectively
and the dashes above the edge of the 95th percentile whisker and below the 5th percentile
whisker denote the maximum and minimum values, respectively.

4.3 Results
4.3.1 Placental Volume
The placental volumes, shown in Fig. 4.5 A illustrate the differences between healthy, PE,
and IUGR placentas at both gestational ages. Median placental volumes for each group
can be found in Table 1. Significant differences in placental volumes are seen across
cohorts (p < 0.001) and with gestational age (p < 0.001), specifically that healthy
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placentas are smaller than those of PE dams (p < 0.001), but larger than those
characterized by IUGR (p = 0.012) and that PE placentas are larger than IUGR placentas
(p < 0.001). A representative, high-resolution image of a PE mouse at E17.5 with two
placentas indicated is shown in Fig. 4.5 B.

Figure 4.5. Placental Volume. A) Placental volumes across cohorts at gestational ages
E14.5 and E17.5. Each data point represents a single placenta. Significant differences in
placental volumes are seen across cohorts and with gestational age. Average placental
volume in healthy dams is significantly smaller than in PE and greater than in IUGR, while
average placental volume in PE is significantly larger than in IUGR. B) Representative
high resolution T2-weighted anatomic image within the mouse abdomen at E17.5 with
yellow arrows indicating placentas.
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Table 4.1. Summary of median parameter values across each cohort of mice
E14.5

E17.5

PE

Healthy

IUGR

PE

Healthy

IUGR

Volume [cm3]

0.056

0.051

0.049

0.065

0.061

0.055

R1 (air) [s-1]

0.26

0.25

0.31

0.23

0.24

0.28

R1 (100% O2)

0.26

0.24

0.30

0.24

0.24

0.29

ΔR1 [s-1]

0

0

0.01

0

-0.01

-0.01

R2* (air) [s-1]

115

130

122

136

139

144

R2* (100% O2)

99

93

92

131

137

146

ΔR2* [s-1]

6

31

12

6

11

-3

Junctional R2*

133

167

142

132

146

147

120

111

115

132

141

151

7

63

8

6

3

-2

117

120

86

130

153

134

114

70

70

112

124

130

12

50

19

9

32

-3

[s-1]

[s-1]

(air) [s-1]
Junctional R2*
(100% O2) [s-1]
Junctional ΔR2*
[s-1]
Labyrinth R2*
(air) [s-1]
Labyrinth R2*
(100% O2) [s-1]
Labyrinth

ΔR2*

[s-1]
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4.3.2 Placental R1 and R1
The average R1 for all voxels within each placenta across cohorts, at both Gas, and with
the breathing gas challenge is shown in figure 4.6 A and median R 1 values for each group
can be found in Table 1. Significant differences are seen across cohorts (p < 0.001) and
with GA (p < 0.001) but not due to the breathing gas challenge. R 1 of placentas in healthy
dams is significantly less than that of PE placentas (p < 0.001) and IUGR placentas (p <
0.001) and, furthermore, IUGR R1 is greater than that of PE (p < 0.001).
The change in average R1 (R1 = R1[air] – R1[oxygen]) between breathing air and oxygen
across all voxels within each placenta across cohorts and at both Gas is shown in Fig.
4.6 B and median R1 values for each group are listed in Table 1. R1 is significantly
different with GA (p = 0.015), but not with cohort. The color map of voxel wise R 1 values
in Fig. 4.6 C for all placentas within a single image from a representative IUGR dam shows
the heterogeneity of R1 across and within the placentas.

Figure 4.6. Placental R1 and R1. A) Placental R1 across cohorts, with the breathing gas
challenge, at each GA. Significant differences in placental R1 are seen across cohorts
and with GA. Average placental R1 in healthy dams is less than in PE or IUGR; average
R1 in PE is less than in IUGR. B) Placental ΔR1 [R1,Air – R1,Oxygen] due to the breathing gas
challenge across cohorts, at each GA. ΔR1 is significantly different with GA. Each point
in A) and B) represents a single placenta. C) Representative color map of R1 values at
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E17.5 in an IUGR dam shows the heterogeneity of R 1 rate constants across and within
each placenta.

4.3.3 Placental R2* and R2*
The average R2* for all voxels within each placenta across cohorts, at both GAs, and with
the breathing gas challenge is shown in figure 4.7 A and median R 2* values for each
group are listed in Table 1. Significant differences are seen across cohorts (p = 0.001),
with GA (p < 0.001), and in response to the breathing gas challenge (p < 0.001). R 2*
values of placentas in healthy dams are greater than those of PE placentas (p = 0.002),
but not different from IUGR placentas. R2* values in placentas of PE and IUGR dams are
not different from one another. The change in average R 2* (R2* = R2*[air] - R2*[oxygen])
between breathing air and oxygen for all voxels within each placenta across cohorts and
at both GAs is shown in figure 4.7 B and median R2* values for each group are listed in
Table 1. R2* is significantly different with GA (p < 0.001) and cohort (p < 0.001). Placental
R2* values in healthy dams are greater than those in either PE placentas (p < 0.001) or
IUGR placentas (p < 0.001), though R2*values in PE vs. IUGR placentas are not
significantly different. The color map in Fig 4.7 C showing voxel-wise R2* values for all
placentas within a single image from a representative IUGR dam shows the intra- and
inter-placental heterogeneity of R2*.
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Figure 4.7. Placental R2* and R2*. A) Placental R2* across cohorts, with the breathing
gas challenge, at each GA. Significant differences in R2* are seen across cohorts, GA,
and due to the breathing gas challenge. Average R 2* in healthy dams is greater than in
PE. B) Placental ΔR2* [R2*Air – R2*Oxygen] due to the breathing gas challenge is significantly
different with GA and cohort. Average placental ΔR2* in healthy dams is significantly
greater than in PE or IUGR. Each point in A) and B) represents a single placenta. C)
Representative color map of R2* values at E17.5 in an IUGR dam shows the
heterogeneity of R2* rate constants across and within each placenta.

4.3.4 Zone-Specific R1 and R1
The average R1 values for all voxels within each junctional and labyrinth zone across
cohorts, at both GAs, and with the breathing gas challenge is shown in Figs. 4.8 A and
4.8 B, respectively. Significant differences are seen in both the junctional (Fig. 4.8 A) and
labyrinth (Fig. 4.8 B) zones with GA (junctional: p < 0.001; labyrinth: p = 0.003) and
breathing gas challenge (p < 0.001). The change in average R 1 value between breathing
air and oxygen for all voxels within each junctional and labyrinth zones across cohorts
and at both GAs is shown in Figs. 4.8 C and 4.8 D, respectively. No statistically significant
differences in either junctional and labyrinth zone ΔR1 due to the gas challenge are seen
with cohorts or GA.
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Figure 4.8. Zone-specific R1 and R1. Placental R1 in the A) Junctional and B) Labyrinth
zones and ΔR1 in the C) Junctional and D) Labyrinth zones. Each point represents a
single placental zone. A) Statistically significant differences in junctional zone R 1 seen
with GA. B) Statistically significant differences in labyrinth zone R 1 seen with GA. C) & D)
No statistically significant differences in either junctional and labyrinth zone ΔR1 due to
the gas challenge are seen with cohorts or GA.

4.3.5 Zone-Specific R2* and R2*
The average R2* values for all voxels within each junctional and labyrinth zone across
cohorts, at both GAs, and with the breathing gas challenge is shown in Figs. 4.9 A and
4.9 B, respectively. Median R2* values for each distribution are listed in Table 1.
Significant differences are seen in both the junctional (Fig. 4.9 A) and labyrinth (Fig. 4.9
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B) zones with GA (junctional: p = 0.005; labyrinth: p < 0.001) and breathing gas challenge
(p < 0.001). The change in average R 2* value between breathing air and oxygen for all
voxels within each junctional and labyrinth zones across cohorts and at both GAs is
shown in Figs. 4.9 C and 4.9 D, respectively. Median R2* values for each group are
listed in Table 1. Significant differences are seen in both the junctional and labyrinth zones
across cohorts (p < 0.001) and with GA (p < 0.001). Junctional zone R2* in response to
the gas challenge is greater in placentas in healthy dams than in PE (p = 0.029) or IUGR
(p < 0.001) placentas. R2* in junctional zones in PE and IUGR placentas are not
significantly different from one another. Labyrinth zone R2* in response to the gas
challenge is greater in placentas in healthy dams than in IUGR placentas (p < 0.001), but
not in PE placentas. Labyrinth R2* values in PE placentas are greater than in IUGR
placentas (p = 0.036).
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Figure 4.9. Zone-specific R2* and R2*. Placental R2* in the A) Junctional and B)
Labyrinth zones and ΔR2* in the C) Junctional and D) Labyrinth zones. Each point
represents a single placental zone. A) Statistically significant differences in junctional
zone R2* are seen with GA and breathing gas challenge. B) Statistically significant
differences in labyrinth zone R2* are seen with GA and breathing gas challenge. C)
Statistically significant differences in junctional zone ΔR2* due to the gas challenge are
seen across cohorts and with GA, with the response in placentas in healthy dams being
greater than in PE or IUGR. D) Statistically significant differences in labyrinth zone ΔR2*
due to the gas challenge are seen across cohorts and with GA, with the response in
placentas in healthy dams greater than in IUGR and the response in PE greater than in
IUGR.
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4.4 Discussion
Optimal timing of early delivery in cases of placental dysfunction is critical. Biomarkers
which can report whether suboptimal placental function supports continued fetal growth
and guide the decision to deliver early are needed. Clinical cases of placental dysfunction
can have many potential causes[36] further complicated by non-uniform classification and
nomenclature[37], increasing the difficulty of establishing reliable biomarkers. Pre-clinical
experiments allow for greater control of external variables in cases of pregnancy
complications and could provide useful direction for future clinical studies.

4.4.1 Placental Volume
Median placental volumes for the healthy cohort at each GA agree well with reported
stereological determinations of murine placental volumes at similar stages of
gestation[38]. Clinical studies have shown that placental volume increases with GA[39,
40], similar to our results. Additionally, differences in placental volume across cohorts are
supported by ultrasound (US) based clinical investigations that postulate abnormal
placental volume is related to low birth weight[40, 41]. However, these 2D and 3D USbased volume techniques have their limitations and are generally restricted to first and
second trimester determinations with conflicting reports of reproducibility[42]. Recent
advances in 3D US techniques which manually combine multiple images allow for whole
placenta imaging with improved reproducibility, but as yet are still restricted to only
second trimester capabilities[43]. MRI’s superior ability to probe the entire abdomen
eliminates this gestational limitation such that placental volumes can be tracked
accurately across gestation, including during the third trimester. We have shown that
murine placental volumes differ across cohorts; placentas in the PE model are relatively
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larger and IUGR placentas are relatively smaller compared with healthy controls. These
volume differences are likely explained by differences in blood flow altering the total blood
volume, as blood volume makes up approximately 50% of the placental volume[44].
Maternal hypertension and improper development of the maternal spiral arteries in PE
placentas have been proposed to result in increased branching and capillary volume
fraction[36], resulting in larger placental volumes. The bidirectional blood flow and multifetus litter in the murine uterus naturally creates a gradient of blood flow to each
fetoplacental unit[45]. The blood flow in the crowded uterine horn is insufficient to
adequately perfuse all of the placentas, an effect that results in smaller placental volumes
in the central fetoplacental units[22]. Clinical studies of placental perfusion and diffusionbased techniques assessed by MRI have shown decreased perfusion and diffusion in
placentas characterized by IUGR[29, 46], supporting the hypothesis that the volume
differences seen are due to differences in blood volume.

4.4.2 Placental R1 and R1
Clinical studies comparing healthy pregnancies with dysfunctional placentas found
significantly higher baseline R1 in placentas complicated by severe FGR[47] and
increased R1 generally in compromised pregnancies[48], similar to our results in IUGR
mice. The unknown causes of FGR in humans complicates interpretation of this increased
baseline R1, however, in mice this could be due to hormonal differences resulting from
the hemiovariectomy. Studies have shown that hemiovariectomy increases follicle
stimulating hormone and decreases progesterone, inducing hyperplasia in the remaining
ovary[49], and could feasibly affect other organs. Bovine studies showed that reduction
of serum progesterone coincided with decreased partial pressure of oxygen within the
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ovarian vein[50]. The increased R1 in IUGR placentas could be due to these systemic
hormonal changes resulting from the hemiovariectomy. The ovaries produce estrogen,
testosterone, and progesterone[51, 52] and removal of one or both can induce systemic
effects[49, 53, 54]. Retrospective R1 measurements within the maternal spinal muscle
visible in our anatomic images also showed increased R 1 in IUGR dams compared to
healthy (Fig 4.10), supporting the hypothesis of systemic differences. The placenta is
responsible for the creation and secretion of certain hormones and signaling molecules
during pregnancy that are known to enter the maternal circulation[55]. Therefore, it is
possible that the dysfunctional placenta is driving the increased R1 seen clinically via
similar systemic effects.
PE Air
PE Oxygen

Healthy Air
Healthy Oxygen

IUGR Air
IUGR Oxygen

0.4

Maternal
Spinal
Muscle
0.3
R1
(s-1)
0.2
E14.5

E17.5

Figure 4.10. Maternal spinal muscle R 1. Each point represents a dam measurement.
Maternal spinal muscle R1 across cohorts, with the breathing gas challenge, at each GA.
Significant differences in maternal R1 are seen across cohorts (p < 0.001) and with GA (p
< 0.001). A post hoc Tukey test shows that the healthy R 1 is less than the IUGR (p <
0.001) but not different from PE and also the PE R1 is less than the IUGR (p = 0.047).
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The breathing gas challenge was expected to induce small changes in R 1, due to the weak
paramagnetic nature of O2[26]. Herein, the R1 response to the gas challenge is near zero
for all cohorts at both gestational ages. Others have reported measurable R 1 differences
in murine placentas in response to variations in breathing gas from 20% to 100% O2[56].
One possibility for the lack of measured R1 response to the gas challenge is that the VFA
sequence lacks the necessary sensitivity to detect the expected small differences.
Studies in healthy human pregnancies have shown that baseline R 1 values decrease with
GA[57, 58] and the change in R1 with gas challenge also decreases with GA[59], with
term-equivalent change in R1 values near zero. A similar decrease in R1 with increasing
GA have also been observed in cases of severe FGR[47]. The necessary precision and
the small anticipated effect make R1 measurements with a gas challenge unlikely to
provide clinically useful results at near-term or term, although it may provide useful results
earlier in gestation when R1 is greater.

4.4.3 Placental R2* and R2*
As R2* is proportional to the concentration of deoxyhemoglobin within the vasculature,
baseline R2* values increasing with GA are likely due to the significant oxygen
requirements of the growing, developing fetus that drive greater exchange of O2 across
the placenta. Placental hemoglobin saturation of O2 has been reported to decrease with
GA[59], resulting in increased baseline R2*. A similar result was previously shown where
the true transverse relaxation rate constant (R2) also increased with GA[57]. Additionally,
in a study comparing R2 values in healthy and FGR pregnancies in conjunction with
Doppler US, it was shown that R2 values in placentas that yielded FGR fetuses were
significantly higher than healthy controls and were correlated with impedance to flow in
103

the uterine arteries as measured by US[60]. We also found significant differences in
baseline R2* across cohorts, however with R2* decreased in IUGR placentas with respect
to healthy controls. As R2* is the combination of R2 (microscopic fluctuations in the
magnetic field) and inhomogeneous broadening due to magnetic susceptibility effects
(macroscopic fluctuations in the magnetic field), the inhomogeneous component may be
masking the changes seen in only R2 had that been measured directly in this experiment.
It is also possible that our particular model for IUGR result from different underlying
causes than the severe cases of FGR in that study.
The decrease in R2* when the mother is breathing 100% O2 is expected due to the
decrease in deoxygenated hemoglobin. This has been shown to occur clinically in healthy
pregnancies[59, 61] and cases of dysfunction[61]. The R2* response to gas challenge
varies across cohorts at E14.5, suggesting this may be a good biomarker of placental
function for pre-term pregnancies, but is diminished at E17.5 to nearly no change. Clinical
reports of R2* response to gas challenge vary greatly with GA[59, 61, 62] and across
cohorts[47, 61].

4.4.4 Zone-Specific R1 and R1
Zone specific analysis of R1 recapitulated the lack of response to the gas challenge seen
in the whole placenta.

4.4.5 Zone-Specific R2* and R2*
To our knowledge, there have been no previously reported R 2* and R2* in zone-specific
regions of the murine placenta. R2* measurements within the junctional and labyrinth
zones show subtle differences. In the junctional zone, both R 2* and R2* show very similar
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trends as those seen in the whole placenta (very little differences in baseline R2* and R2*
with the gas challenge at E17.5), whereas in the labyrinth zone, baseline R 2* and R2*
response to gas challenge show differences at both E14.5 and E17.5. Using our
segmentation and layer determination protocol, the junctional zone makes up more than
50% of the placental volume, which explains the similarity of trends. R 2* measurements
within the labyrinth zone at baseline and R2* with the gas challenge show promise as a
potential biomarker for placental function at both pre-term and term.
Historically, MRI in pregnancy has been used clinically to evaluate abnormal
implantation[63], with more recent studies highlighting MRI’s capability to assess
placental function[29, 47, 64, 65]. Herein, we have used MRI to demonstrate differences
in placental developmental between healthy and models of PE and IUGR with respect to
placental volume. We have also shown that R2* and R2* responses to gas challenge can
distinguish healthy placentas from PE and IUGR placentas and is a promising biomarker
of placental function at near-term and term. Additional studies to confirm these results in
human placentas are needed. Improved markers of placental development and function
could aid in optimal timing of delivery in cases of placental dysfunction.
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Chapter 5: Functional and
Developmental Effects of Zika Virus
Infection and Hydroxychloroquine
Treatment in Murine Placenta
5.1 Introduction
Zika virus (ZIKV) is a mosquito-borne flavivirus which was first documented in monkeys
in Uganda in 1947 and later in humans in other regions of sub-Saharan Africa. ZIKV is
related to other human pathogens such as dengue, yellow fever, West Nile, Japanese
encephalitis, and tick-borne encephalitis viruses[1]. Until recent outbreaks in Micronesia,
French Polynesia, and South and Central America[2], ZIKV was a relatively obscure
pathogen and was largely neglected due to the low numbers of infections in humans and
fairly benign nature of infection. Symptoms of ZIKV infection, historically, range from no
signs or symptoms to influenza-like symptoms which mimic that of dengue and
chikungunya infections, including a characteristic rash[1]. More severe neurological
symptoms

have

been

reported,

including

Guillain-Barre

syndrome[3]

and

meningoencephalitis[4]. In 2015, an epidemic of ZIKV infection and a concurrent drastic
rise in pregnancy-associated microcephaly in Brazil were deemed to be causally linked.
Evidence suggested that ZIKV infection in pregnant women caused congenital
abnormalities, central nervous system abnormalities, fetal growth restriction, and fetal
demise, despite mild symptoms for the mother[5-7].
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Development of animals models of ZIKV infection during pregnancy enabled research
into the causal relationship between maternal ZIKV infection and fetal pathology and
routes of viral transmission[8-10]. One important role of the placenta is to provide an
immunological barrier between mother and fetus and research suggested that a potential
route of ZIKV infection was trans-placental vertical transmission (from mother to fetus)[8]
for which two mouse models of ZIKV infection during pregnancy were established by the
Diamond and Mysorekar labs[9]. Each model required disrupting the normal immune
response. The first achieved this via transgenic female mice (Ifnar1 -/-) bred with wild type
male mice to produce heterozygous offspring (Ifnar1 +/-) that have a mostly intact immune
response. The second model utilized wild type females bred with wild type males, and the
pregnant females received an injection of an anti-ifnar antibody (anti-Ifnar1 mAb) one day
before exposure to ZIKV to make the dams transiently immunocompromised. Both
models resulted in significant levels of ZIKV in the placentas and fetal heads at embryonic
day 13.5 (E13.5), but the transgenic model also resulted in significant numbers of
spontaneous fetal abortions and resorptions at E13.5[9].
Using these established mouse models of ZIKV infection, potential interventions to
attenuate or prevent vertical transmission of ZIKV were investigated[11-13]. Inhibition of
autophagy in human trophoblasts was shown to reduce ZIKV replication and in pregnant
mice, similarly, inhibition of autophagy resulted in reduced placental viral titers[11].
Hydroxychloroquine (HCQ) is an FDA approved antimalarial drug regularly administered
to pregnant women with chronic autoimmune disorders[14] and is a known autophagy
inhibitor[15, 16]. The Mysorekar lab reported that when ZIKV infected pregnant dams
were treated with HCQ, fetal sizes were increased, placental and fetal viral titer numbers
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were reduced, and ZIKV-induced damage to placental tissue was prevented at E14.5[11].
These results were quite promising; however, a typical gestational period for the chosen
breed of mouse is 19 days[17] so further investigations focusing later in gestation were
needed. Additionally, utilizing non-invasive imaging techniques in conjunction with post
mortem tissue analysis would enable investigations into how ZIKV infection and HCQ
treatment affect placental development and function during late gestation. Towards this
goal, the “gentler” transiently immunocompromised model using anti-ifnar antibody
injection was used to increase the likelihood of fetuses going to near term following ZIKV
infection.
Magnetic resonance imaging (MRI) techniques are non-invasive and can probe the
entirety of the body, providing sub-millimeter spatial resolution, such that placental
development across late gestation can be monitored. The longitudinal relaxation rate
constant (R1) has been shown to be directly proportional to dissolved oxygen content
within tissue[18] and the effective transverse relaxation rate constant (R 2*) has been
shown to be proportional to the concentration of deoxyhemoglobin within the
vasculature[19, 20]. By measuring these rate constants at baseline conditions, during
which the mother is breathing air (20% O2), and during a gas challenge, during which the
mother is breathing carbogen (95% O2/5% CO2), the level of placental function and
response to environmental changes can be inferred. Carbogen, with its increased CO2
content, is believed to counteract the vasoconstrictive effect of increased O2[21].
A discoid, hemochorial shape is common to both human and murine placentas; each
displaying three main layers[22], as shown in figure 5.1. The layer most proximal to the
fetus is known as the labyrinth zone in mice and as the ‘fetal placenta’ in humans. This
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layer contains both fetal and maternal blood supply and allows for physiologic exchange
between the two[22]. The middle layer is referred to as the junctional zone in mice and
the basal plate in humans. This region is characterized by maternal blood only, which
flows into and out of the fetal placenta or labyrinth zone in humans and mice, respectively.
The layer furthest from the fetus differs slightly in humans and mice. In murine placentas,
trophoblast invasion extends throughout the decidua basalis, whereas in humans this
invasion continues into the underlying myometrium. Therefore, the third layer of the
placenta in mice is considered to be the decidua basalis and in humans the outermost
region is referred to as the placental bed, encompassing both the decidua basalis and the
myometrium[22]. For the purposes of this study, we focused our attention on the murine
layers that are functionally analogous with the human anatomy and therefore strived to
only segment the labyrinth and junctional zones in our MR images.
As mice have a typical litter size of about 8 fetoplacental units, a difficulty arises in linking
fetoplacental units within a dam across gestation. MRI methods such as bidirectional
arterial spin labeling can be used to non-invasively identify the order of fetoplacental units
within a dam[23]. However, this technique is challenging and requires significant scan
time. As the MRI protocol already included approximately one hour of scan time per
animal per gestational age (GA), we decided to forgo such measures knowing that unique
identification across gestation would not be possible. Furthermore, due to the design and
vasculature of the murine uterus, each fetoplacental unit is exposed to a slightly different
amount of blood flow and delivery of nutrients, respiratory gases, etc. which, are subject
to change with gestation[24]. Thus small differences are expected across fetoplacental
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units within a litter. To counteract this, MRI results are reported as the average value per
dam.

Figure 5.1. A) H&E stained histological image of murine placenta with each layer
annotated and the junctional and labyrinth zones outlined in black. B) Same image
without the labels, with a blue box which indicates the field of view shown in C) magnified
10x. C) Zoomed-in region showing: junctional and labyrinth zones.

The goals of this collaboration with the Mysorekar lab were twofold: investigate the effects
of 1) ZIKV infection and 2) HCQ treatment during late gestation using established mouse
models, non-invasive MRI techniques, and standard biological techniques. Unfortunately,
the standard biological tests on post mortem tissue did not confirm previously published
results and arrived too late to rescue the study.
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5.2 Methods
All animal experiments were approved by the Washington University Institutional Animal
Care and Use Committee and were completed in collaboration with the Mysorekar lab.
All studies were conducted under biosafety level II containment. A pictorial representation
of the protocol is seen in figure 5.2. With the exception of animal handling for the purposes
of MRI, all pre- and post-mortem animal handling was performed by members of the
Mysorekar lab. Pregnant, wild-type mice lacking an intact interferon response due to an
injection of 2 mg anti-ifnar-blocking antibody (anti-Ifnar1 mAb) on E8.5 were infected
subcutaneously in the footpad with 10 3 focus-forming units (FFU) of ZIKV (n=17) or
phosphate buffered saline (PBS) (n=13) at E9.5. Six animals from each cohort were
treated with 40 mg/kg of HCQ while the remainder received placebo PBS intraperitoneally
daily from E10.5 to E17.5.

Figure 5.2. Schematic depiction of experimental design of infection, treatment, and
imaging protocols for pregnant mice. All animals received an injection of anti-ifnarblocking antibody at E8.5 to transiently disrupt the interferon response. At E9.5, all
animals received either ZIKV or sham injection. Half of each group then received HCQ
treatment daily from E10.5 to E17.5. All animals were imaged at E15.5 and E18.5 and
animals were sacrificed and maternal and fetoplacental tissues harvested immediately
following sacrifice.
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To measure placental volume and function, MRI experiments were performed in a 4.7-T
small-animal MRI system (Agilent Technologies, Santa Clara, CA, USA) using a 5 cm ID
quadrature transmit/receive coil with a 9 cm resonator length (RAPID Biomedical GmbH,
Rimpar, Germany) at gestational days E15.5 and E18.5. During the MRI scan, mice were
anesthetized with isoflurane (3% for induction, 1-2% for maintenance) in oxygen (1
L/min), delivered through a nose cone. Once anesthetized, animals were placed in the
supine position in a custom cradle and taped across the abdomen to restrict respiratory
motion. Respiration rate and body temperature were monitored using an MR-compatible
monitoring and gating system (SA Instruments, Inc., Stony Brook, NY, USA). Body
temperature was maintained at 37C via circulation of warm air and the respiration rate
was maintained at ~50 breaths per minute through modulation of anesthesia.
The volume of all placentas (5-10/mouse) were calculated by manual segmentation of
respiratory-gated, T2-weighted, multi-slice fast-spin-echo (FSEMS) images. Figure 5.3
shows a representative example of a manually segmented placenta. The combined
junctional and labyrinth zones were segmented by hand, and then this region was
automatically divided into the two layers based on the relative intensities of each voxel
using Otsu’s method[25].

117

Figure 5.3. Representative murine abdominal MR images at 4.7T and H&E stained
placenta. A) high resolution T2-weighted FSEMS anatomic MR image (125 um x 125 um
in plane resolution) at E18.5 and a B) T2-weighted FSEMS anatomic MR image (250 um
x 250 um in plane resolution) at E15.5 of a single slice within the abdomen of a different
pregnant dam than in A). A single placenta is outlined, with green outlining the labyrinth
zone and yellow the junctional zone. C) H&E stained histological image of murine
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placenta with each of the three layers annotated and the junctional and labyrinth zones
outlined in black.
The FSEMS parameters were: time to repetition (TR) = 2000 ms; initial echo time (TE) =
12 ms; 4 refocused echoes; effective TE = 48 ms; field of view, 4.8 x 6.4 cm 2; matrix, 96
x 256, zero filled to 192 x 256 such that in-plane resolution was 0.25 mm; 0.5 mm slice
thickness; 3 averages; scan time ~ 15 minutes. A series of 3D gradient-echo (3DGE)
variable flip angle (VFA) images with TR/TE = 50 ms/1.74 ms, utilizing five flip angles (5,
10, 15, 30, and 50 degrees) was acquired for R 1 mapping[26]. The flip angles were
optimized for characterizing the following signal intensity model[26]

𝑆𝐼𝑉𝐹𝐴 (𝜃) =

M0 sin(𝜃) (1 − 𝑒 −𝑅1∗𝑇𝑅 )
1 − cos(𝜃) 𝑒 −𝑅1∗𝑇𝑅

in which SIVFA is the VFA signal as a function of flip angle, , and M0 incorporates the
proton density. Using R1 values from preliminary experiments and normalizing M0 to one,
the expected range of SIVFA curves is shown in Figure 5.4 A. Five flip angles were then
chosen to accurately characterize the SIVFA curve and stratify curves for differing R1
values within the expected range. The chosen flip angles overlaid upon the SI VFA curve
for R1 = 0.5 s-1 are shown in Figure 5.4 B. The flip angle that is most sensitive to R 1
differences over the expected range was determined by calculating the derivative of the
difference between the SIVFA curves for R1 = 0.6 s-1 and R1 = 0.4 s-1 and solving for ,
which was approximately 0.4 radians or 22. This calculated flip angle represents the
optimum value for this expected R1 range for a single flip angle. As we were using five
flip angles, we selected a range of flip angles about the optimum flip angle. Furthermore,
in Figure 5.5 we show that the SIVFA curves for the 15 and 30 flip angles have similar
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slopes, and therefore similar sensitivities, as that of the optimum flip angle over the
expected range of R1 values.

Figure 5.4. A) SIVFA curves as a function of  (in radians) for the expected range of R 1
values: R1 = 0.4 s-1 [dashed blue]; R1 = 0.5 s-1 [solid orange]; and R1 = 0.6 s-1 [dashed
yellow]. B) The SIVFA curve for the expected R1 = 0.5 s-1 [solid blue line] overlaid with the
chosen flip angles [orange stars].

Figure 5.5. SIVFA curves as a function of R1 showing the optimal flip angle ( = 22) [solid
purple] and the middle three flip angles ( = 10 [dashed blue],  = 15 [dashed orange],
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and  = 30 [dashed yellow]) from the chosen range of 5 flip angles for the range of R 1 =
0.4 s-1 to 0.6 s-1.
A 3D multi-echo, gradient-echo (3DMGE) image with TR = 50 ms, flip angle = 15 degrees,
and six echoes starting at 1.74 ms with echo spacing of 4 ms was acquired for R 2*
mapping. The echo times used were optimized for the following signal model:
∗

𝑆𝐼𝑇𝐸 (𝑡) = 𝑆𝐼0 𝑒 −𝑡∗𝑅2
where SITE is the signal intensity as a function of time, t, and SI0 is the baseline signal
intensity. Using R2* values from preliminary experiments and normalizing SI0 to one, the
expected range of SITE curves as a function of time are shown in figure 5.6 A. The echo
time that is most sensitive to R2* differences over the expected range was determined by
calculating the derivative of the difference between the SI TE curves when R2* = 130 s-1
and R2* = 70 s-1 and solving for t to find the optimum TE, which was approximately 10.3
ms. The minimum TE of 1.7 ms was dictated by the scanner hardware and the echo
spacing was chosen to be 4 ms such that the final array of 6 echoes was distributed about
the optimum TE, as shown in figure 5.6 B.
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Figure 5.6. A) SITE curves as a function of t in seconds for the expected range of R 2*
values: R2* = 70 s-1 [dashed blue]; R2* = 100 s-1 [solid orange]; and R2* = 130 s-1 [dashed
yellow]. B) The SITE curves as a function of R2* for the optimum TE = 10.3 ms [solid blue
line] and the array of chosen TEs for the acquisition [dashed lines].
Both R1 and R2* mapping images were acquired while the mice were freely breathing
medical air (20% O2) followed by carbogen (95% O2/5% CO2) to modulate tissue and
vasculature oxygenation. Both the 3DGE and 3DMGE sequences were acquired with a
field of view of 4.8 x 6.4 x 1.8 cm3; matrix 96 x 128 x 48 such that the resolution was 0.5
mm, isotropic; 1 average; scan time 3 minutes and 50 seconds, each. Optimal relaxation
rate constants were determined for each voxel via Bayesian probability theory based
software[27]. Following imaging on E18.5, members of the Mysorekar lab collected the
animals for tissue harvesting and biological tests. The mice were euthanized, a subset of
fetal sizes were measured, a subset of placentas were weighed, and the remaining
placental and fetal tissues were harvested for ZIKV titering and histopathological analysis.
The Mysorekar lab also prepared additional animals which received the same infection
and treatment protocol but were sacrificed at E15.5 (n=20) without undergoing any
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imaging. Following euthanasia, a subset of these fetal sizes were also measured and
placental and fetal tissues were harvested for ZIKV titering and histopathological analysis.
Segmentation of MR images was performed on the FSEMS anatomic images and the
regions of interest (ROIs) were then transferred onto the R 1 and R2* maps using VOXA
(VOXel based image Analysis toolset), a suite of custom image processing tools
implemented in MATLAB[28] and co-developed by Pfizer, Inc. and the Mallinckrodt
Institute of Radiology. The statistical significance of reported results was assessed via
ANOVA and two sample t-tests using Origin[29] and the free and open source Jamovi
Project software[30].
Herein, quantitative results are reported in the form of box and whisker plots to visualize
the summary statistics, overlaid with the individual data points. The mean of each
distribution is represented by an open square and the median is represented by the
midline of the box. The top and bottom edges of the box represent the 75th and 25th
percentiles, respectively, and the range which they cover is referred to as the interquartile
range. The top and bottom whiskers represent the 95 th and 5th percentiles, respectively
and the dashes above the edge of the 95th percentile whisker and below the 5th percentile
whisker denote the maximum and minimum values, respectively.
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5.3 Results
5.3.1 MRI Results
MRI-derived Placental Volume
The average MRI-derived placental volumes for each dam, shown in Figure 5.7, illustrate
the developmental effects of both ZIKV infection and HCQ treatment. In ZIKV infected
dams, the resulting placental volumes are significantly different (p = 0.004) by ANOVA.
At E15.5, the median placental volume of the healthy control dams was 0.065 cm3
whereas the median volume for ZIKV infected, untreated dams was 0.059 cm 3.
Surprisingly, HCQ treatment had an even greater impact upon placental volume (p <
0.001) by ANOVA with uninfected, HCQ treated dams having a median placental volume
of 0.056 cm3 at E15.5. ZIKV infected, HCQ dams showed the smallest overall median
placental volume which was 0.048 cm3 at E15.5. Healthy control dams show a modest
increase in placental volume with increased GA, with a median placental volume of 0.066
cm3 at E18.5. ZIKV infected, untreated dams show no change in median placental volume
and uninfected, HCQ treated dams show a modest decrease with increased GA, with a
median placental volume of 0.054 cm3 at E18.5. The ZIKV infected, HCQ treated cohort
shows a large increase in placental volume with increasing GA such that the median
placental volume is 0.057 cm3 at E18.5.
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Figure 5.7. Average MRI-derived placental volumes per dam show reduction due to ZIKV
infection and HCQ treatment. Open boxes represent GA E15.5 and diagonally lined boxes
represent E18.5. White boxes represent untreated animals and gray boxes denote treated
dams. Each filled point is the average placental volume of all fully segmented placentas
within a single dam. Differences as a function of GA are not statistically significant,
whereas ZIKV infection (p = 0.004) and HCQ treatment (p < 0.001) result in significantly
smaller placental volumes by ANOVA.

Placental R1
Average placental R1 per dam, shown in figure 5.8A, in insensitive to maternal gas
challenge, with no statistically significant difference due to the gas challenge, presence
of ZIKV infection, HCQ treatment, or with aging. Median average placental R 1 values for
each cohort while breathing air and carbogen at both E15.5 and E18.5 are shown in Table
5.1.
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Table 5.1
Placental R1 (s-1)

E15.5

E18.5

Healthy

ZIKV

ZIKV+HCQ* Healthy+HCQ*

Air

0.55

0.53

0.51

0.52

Carbogen

0.58

0.54

0.52

0.52

Air

0.55

0.54

0.55

0.51

Carbogen

0.53

0.51

0.55

0.53

The average change in placental R 1 upon switching from breathing air to carbogen, as
shown in figure 5.8B, is nearly zero for all cohorts and there is no statistically significant
difference due to the presence of ZIKV infection, HCQ treatment, or the GA of the
fetoplacental units by ANOVA. All median changes in R1 with gas challenge are less than
0.01 s-1 with the exception of ZIKV infected, untreated dams only at E18.5 when the
median change is 0.014 s-1. Figure 5.8C shows a color map of R 1 values for each voxel
within all placentas contained within a single slice from a representative dam.
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Figure 5.8. Placental R1 show little response to gas challenge and no change with ZIKV
infection, HCQ treatment, or aging. A) Average placental R1 per dam for each cohort, at
both GAs, and on both air and carbogen breathing gas conditions. There is no significant
change in placental R1 due to the presence of infection or treatment nor as a function of
GA or the breathing gas challenge by ANOVA B) Average change in R1 due to the gas
challenge (R1[air] – R1[carbogen]) at both GAs. There is no significantly different change
in R1 in response to the gas challenge due to the presence of ZIKV infection, presence of
HCQ treatment, or the GA of the fetoplacental units. Each point in A) and B) is the
average R1 value of all placentas within a single dam, excluding any fetoplacental units
that showed signs of undergoing spontaneous abortion and resorption. C) Representative
color map depicting the range of R1 values on a voxel wise basis seen within and across
placentas in a single imaging slice for a single dam. Inlaid color bar shows corresponding
R1 values.
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Placental R2*
Average placental R2* per dam, shown in figure 5.9A, is sensitive to GA (p < 0.001) and
the gas challenge (p < 0.001), but there is no statistical significance of ZIKV infection or
HCQ treatment by ANOVA. All cohorts show an increase in R2* on air with increased GA
and a decrease in R2* when breathing carbogen at both GAs. Median average placental
R2* values for each cohort while breathing air and carbogen at both E15.5 and E18.5 are
shown in Table 5.2.
Table 5.2
Placental R2* (s-1)

E15.5

E18.5

Healthy

ZIKV

ZIKV+HCQ* Healthy+HCQ*

Air

96

95

82

91

Carbogen

64

67

63

80

Air

118

108

112

115

Carbogen

99

90

99

87

The average change in placental R2* upon switching from breathing air to breathing
carbogen, shown in figure 5.9B, is statistically different at different GA (p < 0.001) and
with HCQ treatment (p < 0.001), but not due to ZIKV infection by ANOVA. The median
change in average placental R2* for the healthy control dams was 25.0 s-1 and 15.6 s-1 at
E15.5 and E18.5, respectively. ZIKV infected, untreated dams showed a median change
in average placental R2* of 18.9 s-1 and 17.8 s-1 at E15.5 and E18.5, respectively. For
ZIKV infected, HCQ treated dams, the median change in R 2* was 10.7 s-1 and 13.0 s-1 at
E15.5 and E18.5, respectively. And finally, uninfected, HCQ treated dams showed a
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median change in average placental R2* of 8.8 s-1 and 28.5 s-1 at E15.5 and E18.5,
respectively. Figure 5.9C shows a color map of R 2* values for each voxel within all
placentas contained within a single slice from a representative dam.

Figure 5.9. Placental R2* responds to gas challenge differently due to HCQ treatment,
but not ZIKV infection. A) Average placental R2* per dam for each cohort, at both GAs,
and under both air and carbogen breathing gas conditions. ZIKV infection and/or HCQ
treatment do not induce a significant difference by ANOVA, whereas the increase with
aging and the decrease with the breathing gas challenge were both significantly different
by ANOVA, (p < 0.001, for both). B) Average change in R2* due to the gas challenge
(R2*[air] – R2*[carbogen]) at both GAs. There is no significant difference in the change in
R2* due to the breathing gas challenge due to the presence of ZIKV infection. However,
changes resulting from HCQ treatment and as a function of GA are both statistically
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significant (p < 0.001). Each point in A) and B) is the average R2* value of all placentas
within a single dam, excluding any fetoplacental units that showed signs of undergoing
spontaneous abortion and resorption. C) Representative color map depicting the range
of R2* values on a voxel wise basis seen within and across placentas in a single imaging
slice for a single dam. Inlaid color bar shows corresponding R2* values.

5.3.2 Biological Results via Mysorekar Lab
Placental Weights
Placental weights at E18.5, shown in Figure 5.10, were not significantly different due to
ZIKV infection or HCQ treatment by ANOVA. The median placental weight at E18.5 for
healthy control dams was 0.091 g. The median placental weight from ZIKV infected dams
at E18.5 was 0.095 g. Both ZIKV infected and uninfected dams that received HCQ
treatment had median placental weights of 0.096 g at E18.5.

0.14

0.12

Placental
Weight 0.10
(g)
0.08

0.06

Healthy

ZIKV

Healthy+HCQ* ZIKV+HCQ*

Figure 5.10. Individual placental weights at E18.5 for each cohort. Placental weights
reported in grams. White boxes represent placentas from untreated animals and gray
boxes represent placentas from HCQ treated animals. Neither ZIKV infection nor HCQ
treatment resulted in significant differences in placental weights by ANOVA.
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Fetal Sizes
Figure 5.11A shows fetal sizes reported as the product of the crown to rump length (CRL)
and the occipital lobe to frontal lobe diameter (OF) of the skull at both GAs. A loss of
tissue samples due to contamination during storage resulted in no viable samples from
the untreated healthy or ZIKV cohorts at E18.5. The only factor found to be statistically
significant by ANOVA was GA (p < 0.001), while the presence of ZIKV infection and HCQ
treatment did not result in significant differences. Figure 5.11B shows only those fetal size
results from E15.5 and further ANOVA on just these results once again show no statistical
significance of the presence of ZIKV infection or HCQ treatment. Healthy control fetuses
were on average 89.7 mm2 and ZIKV infected, untreated fetuses were on average 82.3
mm2 at E15.5. Fetuses from ZIKV infected, HCQ treated dams were on average 89.3
mm2 and 151.1 mm2 at E15.5 and E18.5, respectively. Finally, fetuses from uninfected,
HCQ treated dams were on average 88.8 mm2 and 147.6 mm2 at E15.5 and E18.5,
respectively.
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Figure 5.11. Fetal sizes measured as the product of the crown to rump length (CRL) and
the occipital to frontal diameter (OF) of the skull. A) All fetal sizes measured following
tissue harvest and fixation in formalin. Fetuses measured at E15.5 are from dams that
were sacrificed at E15.5 and did not undergo any imaging. Fetal sizes at E18.5 were from
dams that were imaged at both GAs. Loss of tissue samples due to contamination
resulted in no viable samples from the untreated healthy or ZIKV cohorts at E18.5. The
only statistically significant factor by ANOVA is GA; presence of infection and/or treatment
do not result in statistically significant differences. B) The same results from E15.5 shown
in A) without the E18.5 results, allowing for a reduced range of fetal sizes. The ZIKV
infected, untreated fetal sizes appear to be trending downward, however neither the
presence of infection nor treatment show statistically significant differences at E15.5.

Fetal and Placental Viral Titers
Figure 5.12A shows viral titer results from fetal heads. Only tissue samples collected from
ZIKV infected animals were used in viral titer analysis, as uninfected samples would all
result in zero FFU. The mean value at E18.5 for ZIKV infected, untreated animals was
90.7 FFU equivalent per gram and ZIKV infected, HCQ treated animals was 59.4 FFU
equivalent per gram. A two sample t-test found the two groups were not significantly
different. Figure 5.12B shows viral titer results from placental tissue. The mean value at
E18.5 for ZIKV infected, untreated animals was 1.35 x 107 FFU equivalent per gram and
the mean value for ZIKV infected, HCQ treated animals was 1.24 x 10 7 FFU equivalent
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per gram. A two sample t-test found the two groups were not significantly different. Figure
5.12C shows the ratio of the fetal head to placental viral titer results. The mean value for
the ZIKV infected, untreated animals was 1.15 x 10 -5 and the mean value for the ZIKV
infected, HCQ treated animals was 5.38 x 10-6. A two sample t-test found the two groups
were not significantly different.

Figure 5.12. Fetal and Placental viral titer results show no difference with HCQ treatment.
A) Fetal head and B) placental viral titer results at E18.5 from the ZIKV infected, untreated
and ZIKV infected, HCQ treated cohorts. While ZIKV in some fetal heads and placentas
was present at reduced levels, the inhomogeneous response to HCQ treatment results in
no significant difference as determined by a two sample t-test in either the fetal head or
the placental results.

5.4 Discussion
5.4.1 MRI Results
MRI-derived Placental Volume
Decreased placental size with the presence of ZIKV infection suggest that the Zika virus
interferes with proper development of murine placenta across gestation. Previous studies
have shown that ZIKV invades trophoblast cells and induces apoptosis, increased
133

nucleation of fetal erythrocytes, and abnormal fetal vasculature[9]. Surprisingly, placental
volume was similarly smaller than those in healthy control dams when treated with HCQ
and smaller still when both ZIKV infection and HCQ treatment were present. One potential
explanation for this effect is that HCQ alters the delivery of oxygen. Chloroquine (CQ),
the

precursor

to

HCQ,

has

been

shown

in

multiple

cases

to

induce

methemoglobinemia[31-33] wherein the relative amount of hemoglobin in an oxidized
ferric form (Fe3+) is increased. Methemoglobin has a very high affinity for oxygen such
that virtually no oxygen is delivered to the tissue via these ferrihemoglobin carriers. Given
the similarities of the two drugs, it is possible that HCQ could also induce an increase in
methemoglobin concentrations and that the resulting smaller placentas are due to
decreased oxygen transfer to the developing placenta. However, the effects of HCQ on
the placental are not well understood, with very few studies having been conducted thus
far[34]. One such study found that HCQ had no negative effects upon cell turnover,
nutrient transport, or cytokine release but increased anti-inflammatory protection and
promoted regeneration or syncytiotrophoblasts in human placental explants[34]. The antiinflammatory protection may explain why the ZIKV infected, HCQ treated placentas
increased significantly in size later in gestation. Whereas the ZIKV infected, untreated
placentas did not show any increase in size from E15.5 to E18.5, placentas from ZIKV
infected, HCQ treated dams greatly increased in size. The end result is much smaller
than that of the healthy controls, but the increase in placental volume seems to suggest
a positive influence of the HCQ treatment.
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Placental R1
The lack of differences in R1 across cohorts or with GAs suggests no major differences
in the amount of dissolved oxygen within the tissue. Due to the slight paramagnetic nature
of molecular oxygen (O2), R1 is linearly proportional to the concentration of dissolved O 2
in tissue. It acts, in effect, as a weak, endogenous contrast agent. The use of a gas
challenge to induce higher tissue oxygenation was intended to elucidate any differential
responses to altered metabolic states. However, the lack of apparent R 1 response to ZIKV
infection, HCQ treatment, GA, or the gas challenge is not entirely surprising or indicative,
as the pO2 effect upon R1 in tissue is known to be quite small[18, 35, 36]. Furthermore,
the inhomogeneity of R1 values within the placenta complicates the situation further and
could be masking any response to the gas challenge or the infection and treatment
protocol. It is possible that changes are occurring within the placenta to which we are not
sensitive using this particular MRI protocol and that these changes are being further
diluted by first averaging across all voxels within each placenta and then averaging across
all placentas within each dam. While Avni, et al. showed a difference in placental R 1 of
about 0.15 s-1 between 100% O2 and 20% O2 maternal breathing gas[37], studies in
human placentas show that R1 response to gas challenge decreases with gestation and
is nearly zero at term equivalent of E14.5[38]. Therefore, it is also possible that we do not
see a response to the gas challenge because our study focused only on late gestation.
Placental R2*
Contrast in R2* is the basis of BOLD MRI, or fMRI, wherein changes in the magnetic
susceptibility of blood due to variations in the ratio of oxyhemoglobin to deoxyhemoglobin
lead to changes in R2*. Oxyhemoglobin is diamagnetic whereas deoxyhemoglobin is
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paramagnetic and an increase in the oxyhemoglobin to deoxyhemoglobin ratio decreases
the magnetic susceptibility differences between the intravascular and extravascular
spaces. This increased homogeneity in the local magnetic field results in a decrease in
R2*. Therefore, when the dams breathe carbogen, the increased oxygen content within
the breathing gas drives an increase in the proportion of oxyhemoglobin and R 2* should
decrease. This expected result is seen for all four cohorts at both gestational days.
Furthermore, the baseline R2* (or R2* on air) is shown to increase for all cohorts with an
increase in GA. This can be explained by the fetal demand for oxygen increasing as the
fetus continues to grow and develop across gestation.
Given the differences in placental volumes, the lack of a difference in R 2* with ZIKV
infection was unexpected and suggests that the volume difference is not due to altered
vasculature. However, studies in ZIKV infected pregnant rhesus macaques have shown
extensive damage to the maternal-fetal interface wherein oxygen transport from mother
to fetus was significantly impeded[39]. HCQ treatment does not appear to greatly affect
the baseline R2*, as a slight, but not statistically significant, decrease in the median R 2*
is seen by ANOVA. However, the change in R2* due to the gas challenge is significantly
affected by HCQ treatment. Delta R2* is generally smaller with the presence of HCQ,
which could be due to the presence of increased levels of methemoglobin reducing the
amount of deoxyhemoglobin in the blood supply before the gas challenge and therefore
the response to the gas challenge. The exception to this trend is that of the uninfected,
HCQ treated dams at E18.5, which show increased change in R 2* due to the gas
challenge. This result is quite puzzling and a better understanding of the effect of HCQ
on healthy tissue is required to determine the cause.
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5.4.2 Biological Results via Mysorekar Lab
Placental Weight & Fetal Size
As noted previously, differences in placental volume across cohorts were found via MRI
methods. However, the wet weights of individual placentas were found to not be
significantly different due to ZIKV infection or HCQ treatment. This suggests that the
placentas of ZIKV infected and/or HCQ treated dams are denser than those of healthy
control dams. ZIKV infection could potentially disrupt normal development of placental
structures, resulting in a denser placenta. HCQ is used to treat inflammatory conditions
such as rheumatoid arthritis and lupus as it inhibits receptors involved in inflammatory
pathways[34]. Many developmental processes are a finely tuned balance between
anabolic and catabolic factors and the decrease in inflammation resulting from HCQ
treatment could disturb this balance, resulting in denser tissue.
HCQ is known to cross the human placenta, as studies have shown similar concentrations
in maternal and umbilical cord blood samples concomitantly collected at the time of
delivery[40]. However, multiple studies focusing on the safety and efficacy of HCQ
treatment for autoimmune diseases, such as lupus or rheumatoid arthritis, have shown
that HCQ exposure during pregnancy does not appear to increase the risk of adverse
outcomes or congenital defects[14, 41-43]. A minority of published works reference
instances of treatment with HCQ and other malarial drugs in the event of malaria
outbreak, prescribed either prophylactically or therapeutically, and stressed cautious use
of the drug in the case of pregnancy due to increased rates of stillbirths, spontaneous
abortions, and congenital birth defects[44]. However, the lack of an effect upon placental
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weight or fetal size herein supports the argument that HCQ in pregnancy does not pose
a threat to normal fetal development.
Potentially the most surprising and concerning result from this study is the lack of a
difference in fetal size due to the presence of ZIKV infection. Previously published results,
in part by our collaborators, using similar infection protocols resulted in significantly
decreased fetal size at GA E13.5[9]. While it is possible that this difference is due to the
fact that our results herein were collected at GA E15.5, that seems highly improbable. In
fact, it was hypothesized that the difference between ZIKV infected and healthy control
fetal sizes would be more pronounced later in gestation as the growth of the ZIKV infected
fetuses would have continued to be retarded. Furthermore, using nearly the exact same
infection and treatment protocol, our collaborators saw a significant increase in fetal size
in ZIKV infected, HCQ treated animals in comparison to ZIKV infected, untreated animals
at E14.5[11] whereas we saw no difference at E15.5. Once again, it is possible, but
improbable, that this loss of differentiation between the groups is due to the increase in
GA by one day. This inability to reproduce previous findings is quite concerning and raises
questions regarding the viability of this study. Unfortunately, fetal size data were among
the last to be collected and analyzed and were not available until after the remainder of
the study was completed. Further experiments would need to be done to understand
where the biology of our animals deviated from that of previously published results.
Unfortunately, this is impossible as most of the tissue samples collected were lost to
contamination.
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Viral Titers
No significant effect is seen in terms of viral titer results assessed within either the
placenta or the fetal head. It is true that both the fetal head and placental viral titer results
show downward trends with HCQ treatment, however this effect is too small to be
statistically significant. Both of these results deviate from previously published results
determined at E14.5[11, 15]. From the viral titer results, we observed a wide range of
ZIKV infection in the placentas and fetuses within a single dam. It is possible that the
HCQ treatment, which was administered via an IP injection, may not homogeneously
disperse to all placentas. Perhaps a more likely explanation is that the daily injections
were not all identically administered, which caused deviations in the response to HCQ
treatments.
The failure to reproduce the biological measures from previous ZIKV studies diminishes
the significance of the MR findings. It is certainly possible that the decision to study ZIKV
infection and HCQ treatment later in gestation led to our investigating only healthier
fetoplacental units, as mice are able to undergo spontaneous abortion and resorption of
unhealthy fetoplacental units. However, the lack of tissue sample precludes further
investigation of these differences. Finally, we did see significant differences in placental
volume across gestation with ZIKV infection and HCQ treatment and R 2* differences with
HCQ treatment via MRI which are reasonable and warrant further investigation once the
biological model is further refined.
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Chapter 6: Conclusion
6.1 Summary
Knowledge of tissue oxygenation and oxygen transport could provide improved diagnosis
and treatment planning for a multitude of pathologies. In this dissertation, we have
investigated MR techniques to non-invasively quantify tissue pO2. In Chapter 2, a
Bayesian probability theory-based, data-driven approach to model selection resulted in
the biexponential signal model providing the most probable of five signal models
compared for both in vivo and crosslinked bovine serum albumin (xBSA) longitudinal
relaxation data. However, when the data are sparse or the SNR is lower, simpler models,
which utilize fewer free parameters, are favored. Furthermore, xBSA displays similar
longitudinal relaxation characteristics as in vivo tissue, and can be used as a tissue
surrogate for further investigations of endogenous modifiers of R 1 measurements in
tissue.
In Chapter 3, xBSA was employed to explore select endogenous confounds to R 1
measurements – temperature, pH, and protein concentration – and to quantify the direct
relationship between measured R1,slow and tissue pO2. Variations in temperature, pH, and
protein concentration exert a relatively larger effect upon R 1,slow than the paramagnetic
relaxation induced by dissolved O2 and must, therefore, be considered when applying
R1,slow-based methods of pO2 quantification. Additionally, significant challenges in
modifying the xBSA sample pO2 and apparent variations in the relationship between
R1,slow and pO2 across xBSA samples, the latter due to likely cross-sample
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microstructural/microenvironmental variability (i.e., variable sample preparations), limit
the feasibility of using xBSA as an R1,slow vs. pO2 reference material.
In this dissertation, we have also investigated MRI methods for monitoring tissue
oxygenation and exchange of oxygen in the placenta. The placenta is vital in maintaining
the health of both mother and fetus, with facilitation of oxygen exchange prominent among
its various roles. MRI biomarkers of placental function would aid in determining the
optimal timing of early delivery in cases of infection or placental insufficiency, wherein
knowledge of whether sub-optimal placenta performance can support continued fetal
development or not is needed.
In Chapter 4, we employed mouse models of common pregnancy pathologies, including
pre-eclampsia (PE) and intrauterine growth restriction (IUGR), which are proposed to be
caused by abnormalities in placental vasculature. It was shown that placental volume and
R2* measures at baseline and with a gas challenge can stratify healthy placentas from
those characterized by PE or IUGR. In particular, R 2* changes due to the gas challenge
in the labyrinth zone show promise as a biomarker of placental function at both near-term
and term, and warrant further investigation.
In Chapter 5, in a collaboration with Indira Mysorekar’s lab, we investigated Zika virus
(ZIKV) infection and hydroxychloroquine (HCQ) treatment effects upon placental
development and function using MRI and biological methods. Volume differences were
found across gestation with ZIKV infection and HCQ treatment and R2* differences with
HCQ treatment were found that warrant further investigation. However, the biological
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methods failed to reproduce results from previous ZIKV studies, diminishing the
significance of our MR findings.

6.2 Future Research
6.2.1 Viable Application of R1,slow-based pO2 Quantification Method
Donor tissues for transplantation are in short supply worldwide, with techniques such as
tissue engineering or in vitro organogenesis providing potential solutions[1, 2]. Lab grown
tissues or organs are not yet widely available due to a lack of tissue scaffolds that can
adequately provide the appropriate oxygen supply for tissue growth. Our R 1,slow-based
method for pO2 quantification could provide a valuable tool for non-invasively monitoring
tissue development in various media to determine the optimal method of delivery of
oxygen to facilitate proper tissue growth and development.

6.2.2 ZIKV Infection and HCQ Treatment Effects Upon Placental
Development and Function
Investigation into the differences seen in biological results of our cohort of mice from those
published previously would be required to interpret our MRI results. However,
unanticipated loss of tissue samples from the current study precludes such investigation.
It has been shown in non-human primates that ZIKV infection causes severe placental
damage and abnormal oxygen transport[3]. HCQ reduces transmission or ZIKV across
the placenta early in gestation and could be a viable treatment during pregnancy[4].
Repeating this study following refinement of the biological model would enhance our
understanding of the placental effects of both ZIKV infection and HCQ treatment.
Furthermore, dose-response studies of HCQ treatment in cases of ZIKV infection for

146

preventing transmission of the virus without retarding fetal development could guide
future clinical studies.

6.2.3 R2* and R2* as Biomarkers of Placental Function
Further investigation into the efficacy of R2* and R2* as biomarkers of placental function,
specifically within the region of the placenta most proximal to the fetus, are warranted.
Studies of healthy human placenta have shown that changes in placental R 2* (R2*) in
response to a gas challenge decrease with gestation[5], as we observed for murine
placenta. Additionally, our measurements of R2* with gas challenge within the labyrinth
zone stratified healthy placentas from those of PE or IUGR, at both near term and term.
This could be further investigated pre-clinically, wherein more severe placental
dysfunction can be induced via i) increased dosage of Poly(I:C) in the PE dams; ii) ligation
or occlusion of the ovarian or uterine artery to restrict blood flow into the uterine horn; iii)
maternal nutrient restriction; or iv) housing under hypoxic conditions. Furthermore,
measurements of R2* could be investigated clinically in mothers to determine if similar
trends are seen within the fetal placenta in healthy term pregnancies and those
characterized by placental dysfunction.
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